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ABSTRACT 
In the investigation of radiation accidents it is of great importance to estimate the 
dose absorbed by exposed persons in order to plan their therapy. Although 
occasionally in these situations physical dose measurements are possible, most 
often biological methods are required for dose estimation. 
The aim of this investigation was to assess the suitability of the cytokinesis 
blocked (CB) micronucleus assay as a biodosimetric method using lymphocytes 
irradiated in vivo. The approach adopted to achieve this was to estimate whole 
body doses by relating micronuclei yields in patients undergoing radiotherapy 
treatment with an in vitro radiation dose-response curve. These biologically 
derived estimates were then compared with the corresponding doses obtained by 
physical measurement and calculation. 
As a first approach a study was performed of the in vitro dose-response of 
gamma-ray induced micronuclei following cytokinesis-block in the lymphocytes of 
peripheral blood samples obtained from 4 healthy donors. The results indicated 
that the distribution of the induced micronuclei were overdispersed. Furthermore 
a linear dose-response relationship was established when a curve was fitted to 
the data by an iteratively reweighted least squares method. By means of an 
analysis of covariance it was demonstrated that this result is in agreement with 
the dose-response relationships found by various other workers (Fenech et al., 
1985; Fenech et al., 1986; Fenech et al., 1989; Balasem et al., 1992, and 
Slabbert, 1993). 
To assess the suitability and accuracy of dose assessment using the CB 
micronucleus assay for in vivo exposure of lymphocytes, blood samples obtained 
from 8 patients undergoing radiotherapy before, during and after treatment were 
examined. The physical doses of these patients were determined according to 
conventional radiation treatment plans and cumulative dose-volume histograms. 
The dose-volume histograms permitted calculation of integral doses and 
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subsequently the estimate of equivalent whole-body doses.The results of the CB 
micronucleus assay applied to peripheral blood lymphocytes of 6 patients 
undergoing fractionated partial-body irradiation showed a dose-related increase 
in micronucleus frequency in each of the patients studied. This demonstrated 
that micronuclei analysis may serve as a quantitative biological measure of such 
exposures. The pooled data of these patients compared to the pooled data of the 
healthy donors show that there was no statistically significant difference between 
in vitro and in vivo results, however a slightly lower induced micronuclei frequency 
was observed after in vivo exposure. 
When the biological dose estimates for equivalent whole body doses obtained 
from the in vitro dose response curve were compared with calculated physical 
doses, it was found that : biologically estimated dose = 0.936 physical dose. 
However there was inadequate statistical evidence to discard the hypothesis that 
the gradient of the equation was equal to one. Therefore the analysis of 
micronuclei induced in lymphocytes in vivo yields highly quantitative information 
on the equivalent whole-body dose. 
The negative binomial method was used for analysing the micronucleus data from 
two patients who received single, relatively larger tumour doses of 10 Gy each, 
with the objective to obtain estimates of the exposed body fraction and the dose 
to this fraction. The dose estimates to the irradiated volume were found to be 
within 30% of the physical tumour dose. The irradiated volume estimates seemed 
to be higher than the physically calculated volumes but by discarding the 
correction for the loss of cells due to interphase death the agreement was good 
between the physically and biologically determined integral doses. 
This study has revealed that the CB micronucleus assay appears to offer a 
reliable, consistent and relatively rapid biological method of whole body dose 
estimation. It is recognised that further corroborative work using the techniques 
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A PERSPECTIVE ON THE BASIC PHYSICS AND BIOLOGICAL 
CONSEQUENCES OF RADIATION ABSORPTION 
1. Introduction 
In the event of radiation accidents involving large population groups 
there are normally no physical procedures for personal dose 
measurement, thus other procedures to access body doses are 
required. During the past two decades it has become increasingly 
possible to correlate biological effects quantitatively to the absorbed 
dose. Various types of biological indicator systems, of which the 
micronucleus assay is one, can be used in an attempt to estimate 
absorbed doses to irradiated persons (Biological Indicators Working 
Group, 1991 ). 
The aim of this study is to evaluate the use of micronuclei in the 
peripheral blood lymphocytes of exposed persons as a tool for 
biological dosimetry. For such an evaluation it is necessary to 
examine the basic principles regarding radiation, radiation dosimetry 
and radiation biology as well as the physiology and radiopathology of 
the haemopoietic system. 
2. Radiation and matter 
2.1 Radiation theory - the duality 
Radiation is a form of energy in motion, which has a duality in its 
basic physical properties. It has both quantum and wave properties. 
It can be thought of as discrete packets of waves called quanta or 
photons. Individually the quanta act like particles ; in large numbers 
they act like waves. When radiation travels from one place to another 
without losing energy the wave aspect (e.g. reflection, interference 
and diffraction) appears. But when radiation interacts with matter and 
gives up energy, then the particle aspects are of major importance. 
However, x-rays and y-rays do differ in their origin, in that x-rays are 
produced extranuclearly and y-rays intranuclearly. These radiations 
are emitted spontaneously by radioactive nuclides, and can also be 
produced by radiation equipment like x-ray units. 
Particulate radiation includes protons, electrons, neutrons, alpha 
particles, heavy charged ions and 1t-mesons. Particulate radiation 
such as beta particles (electrons), alpha particles and neutrons may 
be spontaneously emitted by radionuclides, or produced in devices 
such as linear accelerators or cyclotrons. 
2.5 Natural radiation sources 
The sun emits the entire spectrum of radiation from radio waves to 
cosmic rays, the latter consisting of both subatomic particles and 
electromagnetic radiation. Other major contributors to background 
radiation are the nuclides uranium-235 and uranium-238, thorium-232 
and potassium-40, and their associated decay products, present in 
the earth's crust. 
Radiation from these natural sources contributes about 87% of the 
average individual's total exposure (Fig. 1.1 ). About 50% is due to 
the inhalation of radon daughter products. Radon is a natural 
radioactive gas which emanates from any material containing 
uranium, thorium and their radium decay products. The next most 
important source of radiation to the average individual (about 12%) 
derives from radiography for medical diagnosis (x-rays). Other man-
made sources of radiation such as nuclear tests and nuclear power, 
contribute only about 1 % of the average individual's total radiation 
exposure. (Fig. 1.1 ). 
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2.2 The electromagnetic spectrum 
Radio waves, radiant heat, light waves, ultraviolet rays, x-rays and 
gamma rays are all examples of electromagnetic radiation. The 
electromagnetic spectrum includes all this radiation from the very long 
radio waves with energies in the order of 10·11 eV to the exceedingly 
short, penetrating gamma rays with energies of the order of 1010 eV at 
the other end of the spectrum. It should be emphasized that the 
regions of the spectrum overlap, so there is no sudden change in 
properties as we move from the region of radio waves into the infrared 
region or from the ultraviolet into the x-ray region. (le Roux et al., 
1992). 
2.3 Ionising radiation 
When radiation interacts with matter, including living tissue, its energy 
is absorbed by and dissipated in the atoms and molecules. Radiation 
in the high-frequency range (101s Hz) with energy in excess of 1 O eV 
transfers sufficient energy to eject an electron from the outer shells of 
atoms with which it interacts, resulting in a positively charged ion and 
a negatively charged electron. This process, known as ionisation, 
can ultimately result in biological effects and can best be quantified 
by radiation measuring devices. 
Radiation with quantum energy less than 1 OeV, such as ultraviolet-, 
visible-, and infra-red, light waves, microwaves and radio waves do 
not dissipate enough energy to cause ionisation. 
Although the term radiation is in fact very broad, it is most often (and 
particularly in this text) used to mean ionising radiation. 
2.4 Types of radiation and radiation sources 
Ionising radiation can be classified as electromagnetic or particulate 
radiation. Electromagnetic radiations, as exemplified by x- and y-rays 
are identical in nature and properties. 
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Fig 1. 1 Contribution of various sources to the average individuals 
total exposure. (NRPB, 1989) 
2.6 Radiation dosimetry 
Radiation dosimetry is concerned with the determination of the energy 
absorbed in a medium exposed to radiation. From 1895 to 1937 a 
wide variety of radiation units were proposed and almost every known 
physical action of x-rays and the radiations from radium were made 
the basis for a suggested unit. 
The units were often associated with the names of their proposers. 
The names of Curie and Rontgen were given to units during and after 
this period, but with the adoption of Systeme International (NBS, 
1977) these famous names has been abandoned. However SI does 
resurrect the names of Becquerel, Gray and Sievert to be used in· 
association with units. 
Other units long redundant were the uranie ( 1905), the milligram-hour 
(1921), the millicurie destroyed (1914) and skin erythema dose 
(Mould, 1980). The latter were used independently for both x-rays 
and radium. Other biological units such as the epilation dose 
(Hampson, 1911) and rad unit, (Russ, 1918) base~ on material such 
as rabbit muscle, (Cutler, 1926) ascari eggs, drosophila eggs and 
tadpoles were used for radiation experiments. However, biological-
based dosimeters and units were considered impractical since they 
required too many tests for each measurement. 
The x-unit, (Belot, 1906) based on the ionisation effect, was used for 
measurements of relative intensities soon after R6ntgen's discovery 
in 1895, and Villard (1908) is generally credited as the first to quantify 
this unit. Several units e.g. thee-unit and the R-unit (Solomon, 1925) 
were based on this effect before the rontgen was finally adopted in 
1928, as unit of exposure. During the years ionisation chambers of 
different types shapes and sizes have been designed to measure 
exposure originally in rontgens and more recently in Coulombs per 
kilogram. 
Several of the physical properties of radiation which have been used 
for dose measurement almost 100 years ago are applied in modern 
dosimetry, e.g. scintillation detectors, photographic film, chemical and 
calometric indicators, and calorimetric methods (Knoll, 1979). 
It is interesting to note that the idea of a quantity to specify the 
amount of energy deposited by the radiation per unit of mass ( or of 
volume) was proposed by Christen in 1912, but that it was not until 
1953 that the quantity absorbed dose, and its relevant unit the rad 
[which in SI units became the gray (Gy)] was adopted. The absorbed 
dose can be derived from a measurement of exposure in air, however, 
more recently ionisation chambers are calibrated directly in gray (Gy). 
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2. 7 Interaction between electromagnetic radiation and biological 
matter 
When a beam of photons passes into a biological medium the energy 
of the beam is finally converted into biological damage and heat. The 
sequence of events has been reviewed by a number of authors 
(Johns and Cunningham, 1977 and ICRP, 1990). In brief, the initial 
step in the process involves the collision between a photon and an 
orbital electron, resulting in the scattering of some radiation and the 
setting in motion of a high speed electron. The high speed electron 
produces a track along which ionisations occur, excitation of atoms 
takes place, and molecular bonds are broken. The amount of energy 
which is transferred in such a way is relatively small, about 100 eV 
per interaction for x-rays. 
Most of the electron energy, however, is converted into heat, 
producing no biological effect. Some of the high speed electrons may 
suffer a radiation collision and produce bremsstrahlung. This 
bremsstrahlung, as well as the scattered radiation, can then undergo 
an interaction in the same way as the original photon. Usually, some 
30 interactions are required before all the energy of the photon is 
converted into electronic motion. (ICRP, 1990). 
3. Basic concepts regarding the biological effects of radiation 
3.1 Molecular effects of radiation 
Energy deposited in biological matter by radiation will primarily be the 
cause of damage to important cell structures. This can happen by 
direct ionisation of the macromolecules and subsequent formation of 
free radicals. Since tissue cells are however more than 70% water 
most of the energy is absorbed by water. The net result of this is the 
production of diffusible radical products of the radiolysis of water 
molecules. These radicals are chemically very active. They can 
move rapidly in the medium from the site of the original event and 
indirectly cause further chemical changes in the molecules of the 
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medium before they are inactivated (in times of the order of 10-6 sec. 
or less). (ICRP, 1990). 
Molecular changes reflecting breakage of chemical bonds can 
manifest themselves over various periods of time and in a variety of 
ways depending on the nature of the medium. 
3.2 Cellular effects of radiation 
The eventual morphologic changes induced within cells by irradiation 
will depend on the cell type and radiation dose and may include 
cellular swelling, cytoplasmic vacuolization, mitochondrial 
enlargement, and distortion, disruption, swelling, and fragmentation of 
the endoplasmic reticulum. (Robbins and Kumar, 1987). 
Cell damage from radiation results primarily from the direct- and 
indirect molecular effects which may cause single-strand and double-
strand breaks in the DNA structure. Such induced damage may be 
removed and the original DNA structure is restored. Alternatively 
repair processes may yield errors such that base sequence changes 
(point mutations) or more gross changes such as gene deletions or 
rearrangements (chromosome aberrations) occur (ICRP, 1990). 
These misrepair events may have long term consequences for the 
cell and can result in cell reproductive death or stable genetic 
changes in surviving cells. 
If enough cells are killed in an organ or tissue the function of the 
organ or tissue may become impaired. In extreme cases the 
organism itself may die. These effects constitute what are defined as 
deterministic effects, and with whole-body exposure are classically 
divided into three general patterns : (1) hematopoietic, (2) 
gastrointestinal, and (3) cerebral. 
Stable changes in the genome of a surviving irradiated cell can have 
one of two effects. If the changes take place in the germinal cells of 
the reproductive tissues, they may result in transmissible lesions, 
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which are passed on to and may be manifest as hereditary disorders 
in succeeding generations. 
A second effect is the modification of a normal cell by neoplastic 
transformation. Cancer, which is currently accepted as the most 
dangerous result of exposure to relative low doses of ionising 
radiation, may result. These effects of radiation (where the cell 
structures are changed, but the cells survive) are known as stochastic 
effects. 
3.3 . Factors modifying effects of radiation on cells 
Any type of cell in the body can be damaged or inactivated by 
radiation, depending on the following factors : 
Radiation quantity (Dose) : Damage increases with an increase in the 
radiation dose. The dose-response relationship is, however different 
for deterministic and stochastic effects respectively (see par. 2.5) 
Radiation energy : Although the effects of all types of radiation are 
qualitatively the same, they differ in their penetrability. For example, 
the penetrability of electromagnetic radiation is far greater than that of 
particulate radiation and directly proportional to the photon energy. 
Dose rate : The rate of delivery of radiant energy significantly 
modifies its effect, especially when it is delivered in divided doses or 
fractions, as is the practice in radiotherapy. With low dose rates and 
with dose fractionation, cells are able to repair more of the sustained 
damage, than at high dose rates. 
Unear energy transfer (LET) : For equal radiation dosage, radiation 
delivering more energy per unit path length (high LET radiation) is 
more likely to kill cells than low LET radiation, dissipating less energy 
per unit path length. 
Oxygen effect : Another variable that modifies the effect of radiation is 
the oxygenation of cells and tissues, Molecular oxygen has two 
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unpaired electrons which may interact with radiation-induced free 
radicals to amplify their damaging effect. 
3.4 Quantifying biological damage 
The average energy transfer per unit mass of the irradiated medium is 
known as the average absorbed dose (OT) in the medium T. This 
dose, measured in Gray, is a measure of the biological damage 
caused by a specific exposure. However, the biological damage also 
depends on the linear energy transfer of the specific type of radiation. 
Consequently, biological damage may be more accurately quantified 
by the so-called equivalent dose, HT where 
(Equ 1.1) 
The weighting factor for this purpose is now called the radiation 
weighting factor, wR, and is selected for the type and energy of the 
radiation incident on the body. The equivalent dose is measured in 
sievert (Sv) and is therefore the absorbed dose averaged over a 
tissue or organ and weighted for the radiation quality that is of 
interest. 
The total detrimental effect due to exposure of an individual is the 
sum of the effects attributable to the exposure of the individual 
tissues. The radiosensitivity of different tissues differs. To allow for 
this the ICRP has defined a further quantity by which the equivalent 
dose in tissue or organ T is weighted, namely the tissue weighting 
factor wT (ICRP, 1990). The tissue weighting factor is then used to 
calculate the effective dose E. The effective dose is the sum of the 
doubly weighted absorbed dose in all the tissues and organs of the 
body and is given by the expression: 
(Equ 1.2) 
It is apparent from this that radiation weighting factors are tissue 
independent and tissue weighting factors are radiation independent. 
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The effective dose is also given in Sv. The 1990 ICRP 
recommendations proposes the use of the Effective Dose as an 
adequate surrogate for radiation detriment to an individual and 
Collective Effective Dose for a population. 
3.5 Deterministic and stochastic effects of radiation 
Deterministic effects in humans can result from whole body or 
localised irradiation causing an amount of cell killing that cannot be 
compensated for by proliferation of viable cells. However, as most 
organs and tissues are unaffected by the loss of even a substantial 
number of cells, this mechanism will cause observable (deterministic) 
effects only when such organs are irradiated above a specific 
threshold dosage. Above the threshold the severity of the effect 
increases with dosage, as illustrated in Fig. 1.2. 
Killing is not the only process involved in deterministic effects. 
Functional disorders can also result from direct alteration of other 
cellular processes such as membrane permeability. Despite the fact 
that in slowly dividing cell populations (e.g. nerve cells) death may not 
occur for months or years, deterministic effects are mainly short term 
effects which becomes manifest in rapidly dividing cell populations 
(e.g. stem cells) a few hours or days after exposure. (Scherer, 
Streffer and Trott, 1991 ). 
The second process, taking place in much longer overall times, is the 
modification of a normal cell, presumably the result of molecular DNA 
changes by neoplastic transformation. One characteristic result of 
this change is the potential capability of the transformed cells for 
unlimited cellular proliferation eventually giving rise to an occult 
tumour or hereditary disorders in descendants. These stochastic 
(statistical) effects may be induced even at low irradiation with a 
proportionality equal to the dose. Although no stochastic effects have 
been noted at very low doses, a linear relationship between dose and 
effect, as indicated in Fig. 1.2, is assumed (ICRP, 1990). The interval 
10 
between exposure and the detection of a radiation induced cancer, 
are usually many years, and is referred to as the latency period. This 
period varies with the type of cancer and the age at exposure. e.g. 4 
years or less for leukaemia and up to 20 years or longer for solid 
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Fig 1. 2 Dose response relationship 
3.6 Conceptual framework 
The. basic physical-, chemical- and biological effects of radiation are 
not exact phenomena, and clinical effects are predicted with some 
degree of error. Because of inter-individual variation in radiation 
response, it is only possible to talk about a mean effect of a given 
dose of radiation to which a specific tissue/organ has been exposed 
(UNSCEAR, 1988). 
3. 7 Radiation risk 
Radiation effects are quantified in terms of a risk. 
Probabilistic risk analyses are undertaken to estimate the 
probabilities of e.g. death, defined as the product of the probability of 
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receiving a dose as a result of a precisely defined sequence and the 
conditional probability of death directly as a result of that dose, were it 
to be received. 
It is necessary to project the estimate of probability of e.g. cancer 
induction for the period of observation to the lifetime of the exposed 
population, in order to obtain the full lifetime risk. Among many 
possible choices two principal models have been used for that 
purpose, one the absolute (risk) or additive projection (ICRP, 1977) 
and the other the relative (risk) or multiplicative projection model 
(ICRP, 1990). The former predicts, in its simplest form, a constant 
excess of induced cancer throughout life unrelated to the 
spontaneous rate of cancer while the latter predicts that the excess of 
induced cancers will increase with time as a constant multiple of the 
spontaneous or natural rate of cancer and consequently will increase 
with age in that population. 
The main reason why the new risk estimates are higher than those 
from 1977 is the use of the multiplicative rather than the additive 
projection model. For example the 1977 estimate for fatal cancer 
induction due to whole body irradiation was 1.25%Sv-1 for a 





THE PHYSIOLOGY AND RADIOPATHOLOGY OF THE 
HAEMOPOIETIC SYSTEM 
1. The physiology of the haemopoietic system 
1.1 The bone marrow as haemopoietic organ. 
For an understanding of the . haemopoietic system and in particular 
the Fadiopathology of the system it is necessary to consider briefly the 
anatomical structure and functional organization of the bone marrow. 
The production of the different types of blood cells including 
erythrocytes, leucocytes and thrombocytes (platelets) is called 
haemopoiesis and is normally confined, during extra-uterine life, to 
the bone marrow. 
Bones are composed of cortex and medulla. The bone marrow is part 
of the medulla which is a honeycomb of cancellous bone. As the 
child ages haemopoietic marrow contracts centripetally, to be 
replaced by fatty marrow. By early adult life haemopoietic marrow is 
largely confined to the skull, vertebrae, ribs, clavicles, sternum, pelvis 
and the proximal half of the humeri and femora. 
Bone-marrow can be devided into a vascular and haemopoietic 
compartment. 
The vascular compartment consist of the central nutrient artery which 
enters long bones at mid shaft and bifurcates to two longitudinal 
central arteries. The branches of the central artery give rise to 
arterioles and capillaries which eventually re-enter the marrow and 
open into a network of thin-walled sinusoids. The sinusoids drain into 
the central venous sinusoid which accompanies the nutrient artery. 
The sinusoids are large thin-walled vessels. The walls of sinusoids 
consist of endothelial cells, an incomplete basement membrane and 
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an adventitia. Mature haemopoietic cells enter the circulation by 
passing transcellulary, through sinusoidal endothelial cells. 
The haemopoietic compartment of bone-marrow include the 
haemopoietic cells which lie in cords or wedges between the 
sinusoids. The cells are embedded in a connective tissue stroma 
which occupies the intertrabecular spaces of the medulla. Strama 
cells include cells which have been designated reticulum or reticular 
cells and have a support function. The phagocytic ability of these 
cells is very limited. 
1.2 Haemopoiesis 
There are different views regarding the development of blood cells 
from the so-called stem cells in the bone-marrow. According to the 
polyphyletic theory there is a separate stem cell for each type of 
circulated blood cell. According to the monophyletic theory, however, 
there is a common stem cell for all the different types of circulated 
blood cells - the presently accepted theory (Meyer, 1983). 
Functionally, two main stages {phases) can be identified during the 
development of all blood cell types, namely an undifferentiated and a 
differentiated stage. Undifferentiated cells or stem cells can 
proliferate and deliver a large amount of descendants. Differentiated 
cells on the contrary are specialised to perform specific functions, for 
example, to transport oxygen (red cells), to phagocytose organic 
material (neutrofils and monocytes) or to produce anti-bodies 
(lymphocytes). 
By means of modern techniques it has been demonstrated that the 
so-called three-phase model for haemopoiesis and stem cell 
differentiation (Fig. 2.1) is realistic (Meyer, 1983). 
The upper section of the diagram represents the pluripotent stem 
cells or resting (S) cells. The middle section represents the precursor 
cells. The lower section represents the maturing cells which will 
move into the blood outside the haemopoietic organ. 
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Fig. 2. 1 The three-phase model of haemopoiesis 
1.2.1 Erythropoiesis 
The earliest red cell precursor in the bone marrow is the 
proerythrob!ast, a large cell with a large · nucleus and a thin rim of 
cytoplasm. As the cell divides haemoglobin synthesis starts in the 
cytoplasm, and with successive cell divisions the amount of 
haemoglobin increases. 
After successive cell divisions cells are called normoblasts and are 
classified as early, intermediate, or late, according to (1) the amount 
of haemoglobin present, and (2) the degree of contraction of the 
originally large nucleus. When the cell contains its full complement of 
haemoglobin the small dense nucleus remaining is extruded, leaving 
a reticulocyte. After 24-48 hours in the peripheral blood the 
reticulocyte becomes an erythrocyte. 
The diameter of the mature erythrocyte is between 6,7 and 7,7µm. 
The number of erythrocytes depends on age and sex, and in humans 
there are 4,5 to 6,5 million per mm3 in men, and from 3,9 to 5,6 million 
per mm3 in women. 
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The red cell normally survives in the blood stream for about 110 days 
after which time it is removed by the phagocytic cells of the reticulo-
endothelial system, broken down and some of its constituents 
reutilized for the formation of new cells. 
1.2.2 Leucopoiesis 
Leucocytes can be divided in three main types, the 
polymorphonuclear cells (granulocytes), monocytes and lymphocytes. 
The development of each type differs from each other. 
Granu/opoiesis : The first recognizable granulopoietic cell is the 
myeloblast. This is a large cell with a large nucleus and little 
cytoplasm. As development takes place through successive cell 
divisions the nucleus becomes smaller and loses its nucleoli, at the 
same time the characteristic granules begin to appear in the 
cytoplasm and the cell is then called a myelocyte. As the single 
nucleus becomes bean shaped, and then horse-shoe shaped, the cell 
is called metamyelocyte. When this horse-shoe nucleus forms 
separate lobes, the cell is a true polymorph. 
There are three types of polymorphonuclear cells namely, 
neutrophils, eosinophils and basophils. It is possible to differentiate 
between these cells according to the staining reactions of the 
granules in their cytoplasm. 
Monocytopoiesis : Monocytes are derived from a morphologically 
unrecognizable common granulocytic-monocytic precursor. The 
earliest morphologically recognizable precursor is a monoblast, which 
is larger than the myeloblast with a large nucleus and abundant 
cytoplasm. Monoblasts mature into promonocytes which in turn 
mature into monocytes, which migrate rapidly into the peripheral 
blood. 
Lymphopoiesis : Mature lymphocytes are derived from lymphoblasts 
which are found both in the bone marrow and lymphoid tissues 
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(Gamong, 1993). Lymphocytes appear to concentrate about arterial 
vessels near the centre of the haemopoietic cords. Mainly two types 
of lymphocytes are distinguishable on the ground of their maturation 
processes. Firstly 8-lymphocytes, which are thymus-independent and 
secondly T-lymphocytes which are thymus-dependent (Meyer, 1983). 
8-lymphocytes migrate to the tissues without passing through or 
being influenced by the thymus. These lymphocytes play a major role 
in humeral immunity, and on the stimulation of antigens on the cell 
surfaces, they mature into plasma cells that synthesize humeral 
antibodies. T-lymphocytes either pass through the thymus or are 
influenced by it on their way to the tissues. T-lymphocytes can 
suppress or assist the stimulation of antibody production in 8-
lymphocytes in the presence of antigen and can kill such cells as 
tumor and transplant tissue cells. They are largely responsible for 
cell-mediated immunity and have the property of anamnestic 
response. Several subsets of T-lymphocytes are recognized on the 
basis of surface markers and function, e.g. memory T-cells, helper T-
cells and suppresser T-cells. Other types of lymphocytes that may be 
present in minimal quantities are killer lymphocytes, null lymphocytes, 
transformed lymphocytes and Rieder's lymphocytes. Approximately 
75% of blood lymphocytes are T-lymphocytes and 25% 8-
lymphocytes (Heyns, 1981 ). 
Leucocytes are, in contrast with erythrocytes, nucleated cells. They 
are present in normal blood in smaller numbers than red cells, the 
normal adult range being between 4000 and 11 000 per mm3 of blood. 
Their main function is to act as one of the body's defences and some 
are also thought to be connected with antibody formation. 
1.2.3 Thrombopoiesis 
The earliest morphologically recognizable precursor in the bone 
marrow is the megakaryocyte. The megakaryocytes are classified on 
the basis of their nuclear and cytoplasmic characteristics into three 
stages of maturation. Group Ill megakaryocytes are mature cells, and 
platelets (thrombocytes) are formed by the process of "budding" or 
"pinching off'' of the cytoplasm of this giant multi-nucleated 
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megakaryocyte. Megakaryocytes lie directly outs ide the sinusoid. 
They discharge platelets by protruding cytoplasmic processes 
through the endothelial cells. Platelets are sma ll non-nucleated oval 
or round cells, 2-3µ in diameter. 
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Fig. 2.2 Diagram illustrating haemopoiesis 
2. Radiopathology of the haemopoietic system 
2.1 The radiosensitivity of the haemopoietic system 
Ranked according to radiosensitivity, haemopoietic cells in circulation 
are second only to the germinal cells of the testes (Jandl, 1987). 
Many of the early radiation effects observed in organs and systems 
are mediated by radiation injury of the vascular system. During the 
immediate post-irradiation period, blood vessels may show only 
dilatation, accounting for the erythema of the skin. Later (or with 
higher levels of exposure) endothelial cells undergo swelling, 
vacuolation and even destruction. Heavily damaged vessels may 
rupture, or undergo progressive fibrosis and narrowing of their lumen. 
In this way the dependent parenchymal cells are deprived of their 
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nutrition and thus undergo atrophy and die, much like what is 
encountered in aging. 
Each site of the haemopoietic tissue is in a certain sense primarily an 
autonomous subunit of the whole organ. But in addition, all parts of 
the haemopoietic tissue are interconnected with each other via the 
bloodstream. Consequently, due to the persistent interchange of 
signals and the cellular traffic between all the bone marrow sites, the 
haemopoietic tissue in the whole skeleton is able to respond as a 
single entity to any damage, whether local or involving the whole 
body. 
Perhaps the most important radiobiological principle involved in the 
understanding of radiation damage to the haemotopoietic system 
involves a 'law' postulated as early as 1906 by Bergonie and 
Tribondeau which states: cells that normally often divide are 
radiosensitive; cells that do not divide normally are radioresistant. 
This law holds remarkably well among cell systems, although, as with 
essentially all laws, exceptions do exist, e.g. all lymphocytes appear 
to be extremely sensitive to radiation (see par. 2.2). 
With regard to the radiopathology of the haemopoietic system it is 
further necessary to distinguish between single high dose whole body 
exposure and prolonged chronic or repeated low dose whole body 
exposure. 
2.1.1 Single high dose whole body exposure. 
This type of exposure is identified by the so-called haemopoietic or 
bone marrow syndrome. This syndrome is clinically characterised 
with mild gastrointestinal symptoms related to injury to the gut, 
followed by changes in the peripheral blood and bone marrow. 
Since the pioneer work of Heineke (1903) many workers have studied 
the effect of radiation on haemopoiesis. The subject continues to 
stimulate much interest but is now more concerned with the effects of 
radiation on the pluripotent stem cell pool than on radiation damage 
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to the haemopoietic cells themse lves. It is suggested (Bond 1971) 
that the renewal system should be seen as two separate 
compartments made up of dividing and non-dividing cells. The 
immature dividing cells can be regarded as radiosensitive and the 
more mature non-divid ing cells can be regarded as more 
radioresistant. That this is in fact true is clear from the survival 
curves of stem cells as obtained with numerous experiments 
(McCullogh and Till , 1962; Sinclair, 1968). All these curves indicate 
that a relatively small dose of approximately 1 Gy is required to reduce 
the number of surviving stem cells to 50% of the normal and at LO 50 
values only of the order of 2 to 3 stem cells per thousand retain the 
potential for proliferation. Divid ing cells are rapidly reduced, due to 
either direct- or mitotic cell death, and by maturation of the remainder. 
The chain of events in this case is illustrated in Fig. 2.3. In this 
illustration it is assumed that the non-dividing maturing cells continue 
to mature. The feed into the peripheral blood will therefore be 
constant for a time period approximately equal to the time taken for 
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Fig 2.3 Schematic representation of the events if an earlier "factory" 
cell compartment is selectively depleted, while the more mature "supply" 
cells remain intact. (Adapted from Bond 1971) 
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Effects of radiation on the peripheral blood: The situation described 
above is illustrated diagrammatically in Fig. 2.4 showing the 
percentage of circulating cells plotted against time following whole-
body exposure. (Real values will depend on the specific type of cell 
dose rate and total dose). According to Bond (1971) the curve can be 
devided into 3 sections. 
The degenerative section consisting of firstly the initial shoulder of 
which the width represents the time span from when mitosis ends in 
the dividing maturing bone marrow compartment until the exit of 
mature elements from the bone marrow into the peripheral blood. 
Secondly the initial rapid drop representing the typical exponential 
disappearance time of normal cells from the peripheral blood (the 
half-time depending on the kind of cell). This correlates with the 
sudden and almost total interruption of the supply of normal cells from 
the bone marrow. 
The abortive rise section of the curve, the mechanism of which is not 
clear. The most acceptable explanation is based on stem cells 
damage to the extent that they do not die, but have a limited 
proliferative potential. These cells, having lost their normal 
proliferative capacity, initially proliferate and would result in the 
abortive regeneration. After the limited potential for proliferation is 
exhausted, they and their daughter cells disappear and the supply of 
mature cells is again reduced. 
The recovery section of the curve is related to the relatively small 
number of cells in which proliferative capacity is essentially 
uneffected. These cells will repopulate the stem cell pool and in time 
will produce cells that can mature and feed into the peripheral blood. 
Thus the initial rate of rise of cells in the blood is very slow, but 
increases gradually as the stem cell compartment is repopulated. 
The primary changes will determine the fate of the individual following 
acute exposure. The resultant neutropenia and thrombopenia, with 
subsequent haemorrhage and infection lead to the haemopoietic or 
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Fig 2.4 Percentage of circulating cells as 
a function of time after exposure 
2.1.2 Chronic or repeated low dose whole body exposure 
The effect of continuous exposure is the same as that following on 
single lethal exposures. With decreasing dose rate there is a 
progressive reduction in the haematological injury until the only 
significant change is a small reduction in the number of lymphocytes 
in the circulation. The dose rates considered in this section are, 
however, of such a low level that the bone marrow syndrome will not 
be observed. 
Many elaborate methods have been employed to detect minimal 
haematological changes in workers chronically exposed to radiation 
and different clinical parameters have been used for this purpose. 
Peripheral blood counts : The relation between haematological 
changes and dose is difficult to ascertain. Sievert (1947) found 
changes in persons exposed to x-rays at levels estimated to be as low 
as 0.02 to 0.05 cGy per day. Mayneord (1951) reported a leukopenia 
w_ith lymphocytosis in patients exposed to 0.125 cGy per day. 
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Such results seem to indicate a high sensitivity to radiation. 
However, one must be very careful in ascribing these modifications in 
the blood to radiation alone. More recent experimental results (Bain 
et al., 1992) indicate that in general haemopoietic tissue is not 
particularly sensitive to low-level long-term irradiation and that 
peripheral blood counts may not provide a reliable estimate of the 
amount of radiation received 
Chromosome aberrations : Chromosome aberrations have been 
studied in radiation workers exposed for many years to x- and 
gamma-rays. In leukocyte cultures for these workers the frequency of 
aberrations is significantly higher than that for the population at large 
(Sasaki et al., 1963 and Norman et al., 1964). It appears difficult to 
relate the dose to the frequency of the aberrations. Chromosome 
studies reveal radiation damage; while other criteria are still within 
normal limits. 
Aplastic anemia : With prolonged exposure to moderate doses of 
radiation, the differentiating marrow cells begin to show dysplastic 
nuclear changes that signify ineffective haematopoiesis (Wilson et al., 
1991 ). As exposure continues, the rate of stem cell death increases 
until aplastic anemia is observed. Long-term exposure to small 
amounts of radiation led to an increased incidence of aplastic anemia, 
as was found in radiologists and other occupationally exposed 
persons (Wilson et al., 1991 ). 
Radiation-induced leukemia : The leukemog~nic action of radiation 
first suggested in 1911 by von Jagie, Schwarz and von Siebenrock, 
have since been confirmed by many authors (Betz et al., 1971 ). 
Numerous observations indicate a close relationship between 
radiation exposure and the occurrence of neoplasms, amongst which 
leukemia ( either acute or chronic granulocytic leukemia) has attracted 
the greatest attention. The raised incidence of leukemia observed 
among radiologists in the US is but one example (Warren and 
Lombard, 1966). 
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All the above effects, induced by chronic exposure, are only observed 
a long time (years) after exposure started and are therefore termed 
the late effects of irradiation. Identical late effects are also induced 
by single high dose exposures, as observed amongst others in the 
atomic bomb survivors, patients treated with x-rays for ankylosing 
spondylitis and children irradiated for thymic enlargement. 
2.2 Difference in radiosensitivity of the various blood cell lines 
Lymphocyte count : The white cells and particularly the circulating 
lymphocytes is one of the most sensitive cell types in the body. 
Within minutes to hours after significant radiation exposure the 
lymphocyte count drops. A drop has been demonstrated with whole 
body exposures as low as 0.5Gy, (Gerstner, 1958) and a mild 
decrease was found with doses less than 1Gy (Cyonkite et al., 1964). 
The most recent survival curves, obtained from in vitro exposures 
indicates a 0 0 value between 0.25 and 0.35Gy (Scherer et al., 1991 ). 
Moreover, while most cells do not die until they attempt to divide, 
lymphocytes are killed without entering the mitotic cycle i.e. their 
death is non-mitotic. 
Other white cell types : The change in the counts of the other types of 
white cells differ from that of lymphocytes. Whilst mature 
lymphocytes are killed by radiation, this is much less likely to happen 
to granulocytes, resultantly no drop and even an abortive rise in count 
may occur before a fall begins. Their numbers drop only when the 
disruption of mitotic activity in the bone marrow is expressed in the 
circulating cells. Usually the low point of the granulocyte count in 
humans is about the 30th day after irradiation with a dose of 
approximately 2Gy. A severe depression can be induced in this 
period with exposures between 3 to 5Gy (Saenger, 1981 ). 
Platelets : A moderate decrease in the platelet count during the 3rd 
and 4th week has been correlated with an exposure of less than 2Gy 
reaching its lowest value about 28 days after exposure and 
approaching the normal value in approximately 40 days. A severe 
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depression is induced within 3 to 5 weeks after whole body doses 
between 2 and 5Gy. In this instance the count drops to about 10% of 
the normal value and recovery starts between the 30th and 35th days. 
The recovery rate is somewhat variable, reaching normal values 6 to 
8 weeks after exposure. After sublethal levels of whole body 
exposure (from 4 to 9Gy) the platelet count begins to drop much 
earlier and may approach zero by the end of the first week (Wald. 
1971 ). 
An effort has been made to compare the radiosensitivity of the 
various peripheral blood elements with the dose of radiation to the 
bone marrow (Scherer et al., 1991 ). From the data obtained from 
humans accidentally exposed to radiation, graphs illustrated in Figs. 
2.5, 2.6 and 2.7 have been constructed to show the average time-
response of lymphocytes, neutrophils and platelets respectively with 
four different dose levels. Whole blood counts and particularly 
lymphocyte counts, are the most sensitive parameter to detect 
radiation exposure. 
Red cells : Mature erythroid or myeloid cells are several orders of 
magnitude less radiosensitive than that of actively deviding cells. The 
low point in their count is reached between 40 and 60 days after 
exposure and results exclusively from bone marrow effects, which 
inhibits their production. However due to the fall in platelets, there 
may be bleeding, resulting in a loss of red cells from circulation. The 
drop in red cells may therefore be more rapid than that caused by 
mitotic delay alone. A fall in the reticulocyte count five days after 
irradiation has been found with doses of approximately 3Gy. The 
immediate effects of sublethal doses of radiation on erythropoiesis is 
considerable, as revealed in the depression of the reticulocyte counts 
(Saenger, 1981 ). 
Exposure of erythrocytes in vitro to very high doses of irradiation does 
produce observable effects such as haemolysis, loss of intracellular 
potassium, and increased osmotic fragility. However, even a dose of 
20Gy caused no change in their survival, which again demonstrates 
that changes observed in the red cell count level must therefore be 
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Fig 2.5 Average time-course of lymphocyte changes 
(adapted from Saenger 1981) 
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Fig 2.6 Average time-course of neutrophil changes 
(adapted from Saenger 1981) 
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Fig 2. 7 Average time-course of platelet changes 
(adapted from Saenger 1981) 
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2.3 Problems regarding partial-body exposure 
Exposure of human beings almost always results in an unevenly 
distributed absorbed dose. Knowledge in this respect is mainly based 
on cases of incidental overexposure. With heterogeneous exposures 
it is important to distinguish between biological parameters indicating 
total dose, regardless of the proportion or anatomical region of the 
body being exposed, and those which are only a measure of the 
clinical outlook in cases of suspected radiation injury. 
The . stem cells : If the decisive factor regarding the haemapoietic 
syndrome is the degree of radiation damage induced in the stem cell 
population, the prognosis of the exposed individual will be the same 
for the same fraction of surviving cells, irrespective of partial or whole 
body exposure. Theoretically the fraction of surviving stem cells 
could be calculated if the following are known (Cronkite, 1971) : 
(a) the absorbed dose within the active 
marrow in the various parts of the body. 
(b) the survival curve for stem cells of the 
marrow. 
If this approach is correct, the fraction of surviving stem cells at a 
lethal dose point (say LD50) should be the same whether the exposure 
was uniform or not. Experimental results indicate that the approach 
seems to be valid and may provide a technique for handling the 
difficult problem of non-uniform exposure (Cronkite, 1971 ). These 
results also lend weight to the theory (see 2.1) that the haemopoietic 
system, consisting of independent compartments, acts as a single 
integrated system in as far as supplying mature blood cells to the 
common blood pool. 
It has been suggested that in cases of acute exposure the lymphocyte 
can serve as an integrating dosimeter providing an indication of total 
dose regardless of the part of the body exposed (Whitfield et al., 1965 
and Fenech et al., 1990). Whether radiation effects on lymphocytes 
is helpful or potentially misleading, in evaluating specific cases of 
radiation exposures, will depend ultimately on the information 
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regarding the absorbed dose-response relationship for non-uniform 
exposures. 
However, experimental results indicate that the consequences of 
marked inhomogeneities in the absorbed dose are variable, making it 
difficult to estimate the exposure dose (Lloyd et al., 1991 ). It seems 
to be essential that the biological limitations of such integrating 
biological dosimeters be recognized when one is attempting to 




BIOLOGICAL INDICATORS TO DETECT AND QUANTIFY 
RADIATION EXPOSURE 
1. Introduction 
In addition to physical methods of dose assessment, appropriate 
biological indicators have become available to detect and quantify the 
extent of radiation exposure. Minimum requirements for a useful 
biological dosimeter are the following: 







Dose effect relationship 
Persistence of effect 
Sensitivity 
Specificity 
Early availability of results 
The various types of biological indicator systems that have been used can 
be divided in four main groups namely, biophysical indicators, 
biochemical indicators, immunological indicators and cytological 
indicators. 
lri this Chapter it is envisaged to deal with the changes in these 
parameters in a quantitive manner, whereby a dose-response can be 
characterized with sufficient accuracy to allow a valid assessment of the 
physical dose. 
The difficulty in interpreting biological data obtained from non-uniform 
exposure or after multiple exposures makes the limitations of this 
approach even worse. 
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2. Biophysical indicators 
2.1 Electron spin resonance (ESR) 
Ionizing radiation produces free radicals in almost any material. By 
analyzing these radicals by means of ESR a reconstruction of the 
accident can be made which will help to obtain post exposure dose 
assessments (Swartz et al., 1972). 
Radiation induced radicals can only be identified by ESR spectroscopy 
and used for dosimetry if they are stable for some hours or days. 
Consequently only radiation effects in solid state substances are of 
interest for dosimetry, because the majority of reactions of radiation 
induced radicals in water-containing samples generally occur within a 
time of less than 10·2 sec (Brady et al., 1968). 
Typical radiation induced radicals produced in solid substances are : 
(a) radicals resulting from abstraction or addition of hydrogen 
radicals: 
MH---+ M + H 
MH + H·---+ MH2·, 
(b) sulphur radicals insofar as SH-groups are present in the 
substances : 
R + M-SH ---+ RH + MS·. 
(c) electrons or holes, trapped in the lattice of crystals. 
In man, these radicals may occur after irradiation of the bone and teeth, 
which both contain hydroxyapatite and other inorganic components 
(Desrosiers, 1991 ). 
For both bone and teeth a linear correlation was found between the 
radical concentration and the radiation dose applied over a wide range 
using electron spin resonance. The lowest detectable doses are 
approximately 0.5 Gy for teeth and 1 Gy for bone with a linear dose effect 
relationship up to 1.5 x 1 Q4 Gy (Dziedzic-Goclawska and Ostrowski, 
1974). 
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2.2 Neutron activation analysis 
For neutron activation, the subject or sample needs to be exposed to 
either a neutron beam or a mixed beam, of which the neutron-gamma 
ratio is known. Nuclear reactions take place, producing several 
radioactive products, which decay with half-lifes ranging from a few 
seconds to several days. The decay is usually associated with gamma 
radiation. By measuring the gamma ray energies and intensities specific 
elements can be identified and the induced activity thereof be determined 
(Sims, 1989; Straume et al., 1994; Straume et al., 1992). The induced 
activity is directly proportional to the neutron flux to which the sample 
material was exposed. 
For dosimetry purposes the concentration of sodium-24 in the body is 
usually determined, either by whole body counting, or in various body 
fluids. Other radionuclides activated and conceivably available for 
analysis would be 32P, or for instance 19BAu in tooth fillings or in jewelry 
(rings, etc.) worn by the accident victim. The neutron activation analysis 
technique has been successfully employed in the dosimetry of the Oak 
Ridge criticality accidents (Auxier, 1961) and more recently in the 
dosimetric analysis of a serious reactor accident in Argentina (Hubner et 
a/., 1986). 
3. Biochemical indicators 
Biochemical changes are known to occur in the body following radiation 
exposure, e.g. changes in enzyme activities, in the metabolism of nucleic 
acid, as well as changes in cell membranes and of the concentration of 
different metabolites in blood and urine. Some of the problems with this 
type of biological indicators are its time-dependency and limited duration 
after exposure, as well as the lack of a consistent dose response 
relationship for humans (Biological Indicators Working Group, 1991 ). In 
addition there are considerable metabolic differences between animals 
and man, so that animal experiments may therefore only be extrapolated 
to man to a limited extent (Gerber 1986). However, a brief description is 
given of some of the potential biochemical indicators. 
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3.1 Enzymes 
Radiation-induced chemical changes are reflected by measurable 
changes of certain enzyme levels in the blood serum and urine as a 
function of dose and time after exposure (Biological Indicators Working 
Group, 1991 ). These changes are the result of the radiation-induced 
release of enzymes from the cell nucleus, the mitochondria and cell 
membranes because of sufficient damage to the cells or even cell death. 
Enzymes may be released and others may not be synthesized following 
irradiation. Consequently there may be an increase in the level of some 
enzymes and a decrease in the level of others. 
Increases of enzyme levels after irradiation have been reported for 
esterases, alkaline phosphatase, 11-glucuronidase and creatine kinase 
(Stamm et al., 1981 ). 
One of the more promising potential enzyme indicators is amylase, which 
is released into the blood after the parotid gland has been irradiated 
(Stamm and Bagi 1982). A relationship between irradiation of the parotid 
gland with doses of 2 to 20 Gy and the increase of amylase in the blood 
serum and, concommittantly, in the urine was demonstrated. The 
amylase levels in blood and urine peak about 30 h after exposure and 
returns to normal after about 72 h. This suggests that serum amylase 
may be a biological indicator as long as the irradiated tissue volume 
includes the parotid gland. 
3.2 Amino acids and other metabolites or catabolites 
Amino acids and other smaller compounds which are either metabolised 
or catabolised have been examined as potential candidates for 
developing biochemical dosimetry. Taurine, for example is an amino acid 
which appears in the blood serum and in the urine as a function of time 
and dose following irradiation. For taurine a peak concentration was 
observed 24 h after absorption of doses up to 8 Gy (Feinendegen, 1986). 
More recent data appear to confirm a linear dose effect relationship for 
taurine (Biological Indicators Working Group, 1991 ). This may, however, 
not be generalized or extrapolated to other amino acids. 
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Another, and possibly more prom1s1ng indicator in the serum is the 
thymidine level. It was established (Stamm et al., 1983) that total body 
irradiation causes an increase of the serum thymidine level in a dose-
dependent fashion at low doses. In mice the assay is sensitive to 
between 0.005 to 1 Gy. If standardized, this assay certainly holds 
promise to be a sensitive and useful biological indicator. 
Other amino acids which are transiently present in the serum after 
irradiation, such as cysteine, valine and leucine as well as 
aminoisobutyric acid a metabolite of thymidine, were found to be elevated 
in radiation accident patients (Catravas 1982). A dose dependency could 
however, not clearly be shown, especially for doses of less than 1 Gy. 
3.3 Changes in cellular metabolism and membranes 
Altered cellular metabolism has been studied as another possible 
biological indicator. This method is based on the rate of incorporation of 
labeled DNA precursors, such as 3H or 14C labeled thymidine or 1251 
labeled iododeoxyuridine, into DNA of cultured cells. A depression of the 
rate of incorporation of these precursors was observed as a function of 
absorbed dose. The lower region of dose, where significant effects could 
still be observed was close to 0.5 Gy (Huber et al., 1986). It was 
predicted that with improvement of experimental procedures this lower 
limit may eventually be less than 0.01 Gy. 
A reduction in the electrophoretic mobility was observed in the cell 
membranes of several different types of cells after radiation exposure. 
This effect shows a linear dose dependence from 0.25 Gy up to about 
2 Gy and depends on the ionic strength of the medium. The mechanism 
of this effect is based on the displacement of acid sugars on the 
membrane. The reduction in the electrophoretic mobility reaches a 
minimum value approximately 4 hours after exposure. Cells can repair 
and normal mobility restored in intact cells within 24 h (Koteles, 1982). 
The lectin-binding technique which reveals early dose- and time-
dependent alterations was suggested as another potential procedure for 
dose determination (Kubasova et al., 1981 ). Different types of cells, 
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irradiated either in vitro or in vivo, were used, and functional alterations of 
lectin-binding sites on cell surfaces investigated. The lectin 3H-
Concanavalin A (3H-Con A) was used. The amount of bound radioactivity 
was measured by liquid scintillation spectrometry, and it was proved that 
radiation causes a rather early and dose-dependent increase in the 
binding of radioactive lectin. 
3.4 Reduction in the diameter of human hairs 
The measurement of damage to growing human hairs exhibits potential 
for use in biological dosimetry, especially in cases of non-uniform 
overexposure. Hairs have been proposed as a potential dosimeter 
because they are located over much of the body surface, they are rapidly 
proliferating and damage will be expressed in a short time-scale (Wells 
and Charles, 1982). 
Geng and Patten (1990) found that reduction in hair diameter to be dose 
dependent over the range from 3 to 14 Gy. When the diameter was 
reduced by ~so% the hairs broke and were lost from the study, thus 
marking the upper limit of sensitivity of the test. According to the 
available data points, the percentage reduction in diameter for human hair 
is of the order of 2,4% per Gy (Sieber et al., 1992). At present it is not 
possible to say whether measurement of the reduction in hair diameter 
will have a role in biological dosimetry, however, for localized exposure in 
the range from 3 to 14 Gy it might be useful in an accident situation. 
4. Immunologic indicators 
A number of immunological tests have been evaluated as potential 
biological indicators of radiation dose. The value of these tests depends 
in part on the duration of the effect, a demonstrable dose response, 
individual variability and other confounding factors (Doria et al., 1982). 
Some of the more important immunologic indicators are detailed in the 
following sections. 
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4.1 Absolute and relative numbers of lymphocyte subpopulations 
Lymphocytes consist of two major groups, namely B lymphocytes and T 
lymphocytes. T lymphocytes can be divided into several subpopulations 
which differ with regard to their radiosensitivity. Consequently changes in 
the ratio of B and T lymphocytes as well as changes in the ratios of the 
various subsets of T cells have been identified after irradiation 
(Wasserman et al., 1982). B cells appear to be particularly sensitive 
although repopulation occurs rapidly ( days to weeks) if haematopoiesis 
has not been irreversibly damaged by the radiation. It is therefore not 
possible to use the subpopulations of lymphocytes as an indicator of 
radiation dose long after exposure. 
4.2 Production of specific antibodies in vitro 
The pokeweed mitogen (PWM) induced immunoglobulin (lg) production 
test involves the isolation of lymphocytes from peripheral blood and their 
incubation in vitro in the presence of PWM. After seven days the 
immunoglobulin production is measured. This test is difficult to 
standardize and has not yet proved itself as useful for dosimetry 
purposes. The suppressive production effect of the radiation is likely to 
depend on the dose. In radiotherapy patients it was found that the 
decreased production of immunoglobulin classes lgM, lgG, lgA recover 
slowly and the phenomenon was still present after 12 to 18 months 
(Wasserman, 1986). 
4.3 Lymphocyte stimulation test (LST) 
This test (previously mentioned in par. 3.3) is based on the measurement 
of thymidine incorporation into DNA after stimulation of the lymphocytes 
with either Concanavalin-A or by nonproliferated lymphocytes from 
another individual (Petrini et al., 1982). A dose-effect relationship has 
been shown for human lymphocytes in vitro after high doses of radiation 
(1 Gy to 6 Gy). These tests are however only of value soon after 
radiation exposure, and dose estimation of exposures that occurred years 
earlier is not possible. 
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4.4 Somatic mutation assays 
Somatic mutations may be induced by ionising radiation. Methods for the 
quantitative detection of somatic mutations in man are limited, although 
scientists in California adopted a novel approach to this problem (Conner, 
1988). 
The technique exploits the fact that human erythrocytes have two forms of 
glycophorin A located in the membrane of the cells. These two forms 
called GPA(M) and GPA(N) differ slightly in their structures, with different 
genes coding for the two proteins. 
Radiation damages the gene responsible for GPA(M), so stem cells that 
receive a dose of radiation will divide to produce daughter cells that lack 
the GPA(M) protein in their cell membranes, and only have GPA(N). The 
researchers from Lawrence Livermore have devised a technique for 
labelling and counting cells that possess GPA(M) and GPA(N) protein. 
Monoclonal antibodies are used, which recognise and bind to specific 
proteins. The antibodies binding to GPA(M) are also bound to a red 
fluorescent dye, while those bound to GPA(N) are labelled green. Those 
cells damaged by radiation, and which therefore do not have GPA(M), are 
only green. Each type of labelled cell is counted by means of a 
fluoresence activated cell sorter. 
Recently, other methods for the detection of somatic mutations at specific 
loci have been established (Akiyama et al., 1992). These somatic 
mutation assays will have possible applications for use as biological 
dosimeters. However the restricted availability of the specific monoclonal 
antibodies, and the need for well-trained personnel to perform the 
analyses are major disadvantages for the use of these assays in a large-
scale survey. 
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5. Cytological indicators 
5.1 Spermatogenic indicators 
The high degree of germinal epithelium sensitivity to radiation has been 
substantiated by methodical investigations after acute (Oakberg and 
Heller, 1966) and chronic (Wendt, 1971) exposure to radiation. The 
spermiogram is a sensitive cellular assay for radiation exposure, and 
changes in sperm count, sperm motility, and sperm morphology following 
exposure to ionising radiation have been described (Oakberg and Heller, 
1966; Suzuki and Withers, 1978). 
A decrease in sperm count may not be observed until approximately 45 
days after exposure. This delay provides for baseline data to be obtained 
before the radiation effect occurs, however, at the same time it is the 
basic reason why a sperm count is of no practical value for early 
dosimetry or diagnosis of radiation injury. Methods based on change in 
spermatogenesis are useful in estimating the dose following exposures as 
low as 0, 15 Gy, which still cause a severe decrease in the sperm count 
within seven weeks (Oakes and Lushbaugh, 1952; Hasterlik and Marinelli, 
1956; Heller, 1967). 
Hacker et el. (1982) found that with regard to spermatogenesis the DNA 
synthesizing cells are extremely radiation sensitive and are best suited as 
indicator for radiation exposure. Results from a quantitative relationship 
between radiation exposure and a reduction in the number of DNA 
synthesizing cells are so far only available from mice experiments. The 
authors, however, suggest that the dose effect curve obtained by them is 
adaptable to man. 
Recovery of sperm numbers and fertility would make this biological 
parameter unsuitable for the estimation of dose years after exposure. 
5.2 Haematological indicators 
Haematological parameters are unequivocally the most popular biological 
indicators to evaluate the severity of injury resulting from radiation 
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exposure in man. Measured haematological changes as a direct indicator 
of the severity of radiation injury (i.e. the response-injury relation) 
provides useful information to the clinician for diagnosis and prognostic 
evaluation. Dose-response relationships based on different blood 
parameters have been accumulated from various sources during the past 
decades. A brief summary of these is given below. 
5.2.1 Erythema : As mentioned before erythema is a dose-related 
phenomenon due to the dilatation of blood vessels. Skin erythema 
doses have been discussed by Failla et al. (1922) for radium, and 
by Schall (1932) for x-rays. This effect corresponds to a minimal 
absorbed dose of 3 to 8 Gy to the skin. The energy of the radiation 
will determine the exact threshold dose required to produce this 
effect. Less energetic radiation is more effective in this regard. 
With low energy radiation (140 kV), the dose decreases with depth 
from the surface reaching about 80% at 6 mm. More energetic 
radiation (200 kV) shows a region of almost constant dose for the 
first 2 to 4 mm followed by an exponential decrease. Ionising 
radiation of energy of about 1 MeV exhibits a rise in dose for the 
first 2 mm to reach a broad maximum extending over several mm. 
As the energy is still further increased, the surface dose becomes 
smaller and the maximum occurs at greater and greater depths, 
with a resultant skin sparing effect. The phenomenon is explained 
in terms of electronic "buildup". With high energy radiation the 
electrons set in motion by the radiation are projected primarily in 
the forward direction. Hence, the number of these electron tracks 
will increase with depth until a depth equal to the range of these 
electrons is reached. From this point on, the dose decreases with 
depth, due to the attenuation of the radiation. Hence, the dose 
rises from a small value on the surface to a maximum and then 
decreases. With low energy radiation, the range of the electrons is 
so small that this effect is not observed and the dose falls 
continually with increase in depth. 
In addition to the radiation energy dependence skin erythema is 
inconsistent. It may appear after approximately 72 h, vanish and 
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reappear. Normally, the earlier the appearance of erythema the 
higher the dose. 
5.2.2 Telethermography : Two methods, i.e. thermal and radioisotopic 
methods, provide valuable information on the response of skin 
blood flow to irradiation (Flury-Herard, 1986; Lushbaugh et al., 
1986; Jammet and Gongora, 1981 ). Dilatation of blood vessels as 
well as radiation injury of tissue is indirectly responsible for an 
increased blood flow in exposed areas of the body. This causes, 
from exposure onwards and before the appearance of any clinical 
symptoms, a hyperthermia (20c or more) of the irradiated areas. 
The thermal methods can be very simple, using liquid crystal 
thermography (Jammet et al., 1980). Telethermography is more 
accurate, and may exhibit differences of temperature up to soc 
between two symmetric areas, exposed and non-exposed (Flury-
Herard, 1986). This method enables isothermic curves to be 
drawn up which can be compared with isodose curves of physical 
dosimetry, but clearly only provides for a relative dose evaluation. 
5.2.3 Vascular scintigraphy : With the use of radioactive nuclides the 
recording of the vascular circulation in irradiated regions and the 
establishment of vascular circulation curves is possible. Changes 
in the rate of flow precede any clinical evidence of exposure. The 
radioisotopic method consists in recording the vascular circulation 
in the irradiated regions by means of a scintillation camera after 
intravenous injection of ssmTc (300-800 MBq) (Flury-Herard, 1986). 
The severity of vascular changes depends on the radiation dose. 
A severity (isoactivity) gradient can be drawn up but it is not 
possible to establish absolute dosimetry unless the physical 
dosimetry is known. This method also enables long-term 
surveillance of radiation lesions. 
5.2.4 Peripheral blood elements : Because the blood-forming organs 
are extremely radiosensitive changes of cell concentrations in 
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blood and bone marrow might be considered obvious and most 
useful biological indicators for radiation exposure. As indicated in 
Chapter 2 the haematologic response to doses of ionising radiation 
has been extensively described (World Health Organization 1961; 
IAEA 1967, 1969; Bond eta/., 1965). 
The system is approximately quantitative and dose related above 
0.5 to 1 Gy whole body dose. An estimate of dose can be obtained 
by using the typical granulocyte, platelet or lymphocyte response 
after total body irradiation (Thoma and Wald 1959; Andrews 1967; 
National Academy of Sciences, 1967). Due to recovery from 
radiation exposure (following repopulation of the bone marrow) the 
reduction in numbers of blood cells is transient. Therefore, the 
utility of this biological indicator is limited to days or a few weeks 
after exposure, depending on dose and recovery of the bone 
marrow. 
5.2.5 Stem cell and progenitor cell compartments : Another dose-
response approach has been to observe changes in the pluripotent 
stem cells and the progenitor cells of the different cell lineages 
from where blood cell production originates. Due to their 
proliferative state these cells are the most sensitive to ionising 
radiation. Therefore, one may assume that the analysis of stem-
and progenitor cell alterations in principle will be the appropriate 
approach to an assessment of radiation damage to the bone 
marrow. This concept is based on the fact that haemopoietic stem 
cells and progenitor cells are located not only in the bone marrow 
itself, but are also present in the circulating blood. Their 
concentration is in the order of 100 per ml blood. These 
haemopoietic blood cell populations are in a dynamic equlibrium 
with the corresponding compartments located in the different bone 
marrow sites that are distributed over the whole skeleton. 
Nonuniformity of exposure is biologically significant if one 
considers that the bone marrow is spread over the entire body. 
Clearly 1 Gy to 10% of the body will cause less damage to the total 
bone marrow mass than 0, 1 Gy over the whole body. Sequential 
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studies on the changes of the stem cells in the blood after whole 
body irradiation are quite rare, due to the technical problems 
associated with the assay in this special case (Barnes and Loutit, 
1967). The results obtained show for most stem cells a simple 
exponential dose response in the dose range from Oto 3 Gy (Grilli 
et al., 1982). In the case of partial body irradiation the decrease is 
proportional to the irradiated bone marrow volume. Regeneration 
of the stem cell and progenitor cell populations in the blood occur 
more slowly than in the bone marrow (Nothdurft et al., 1983). 
5.2.6 Bone marrow cellularity : The assessment of bone marrow 
cellularity can be performed only under conditions where bone 
marrqw samples of a defined volume can be obtained by biopsy or 
resection of pieces of bones. The determination of the bone 
marrow cellularity can be absolute, i.e. total cell number contained 
in a certain volume of bone marrow, or by the assessment of cell 
density, i.e. counting the cells per mm2 of bone marrow (Stein 
1972). 
In dogs the early changes in bone marrow cellularity after whole 
body irradiation were determined in several samples of bones 
representative for different regions of the skeleton (Wilson et al., 
1978). The depression in cell number 24 h after irradiation showed 
an approximately exponential dose response. 
5.2.7 Bone marrow mitotic index : The mitotic index (Ml) in normal 
bone marrow, although subject to a relatively wide variation, has a 
value of the order of 0.8% for all haemopoietic cells together 
(Fliedner et al., 1959). 
Studies of bone marrow preparations from the patients in the Oak 
Ridge accident carried out by Fliedner et al., (1960) showed 
significant deviations from the normal mitotic rate at four days after 
exposure. An initial depression and a temporary normalisation of 
the Ml has been observed at about the 8th day, after which a 
renewed reduction took place, followed by a progressive increase. 
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There was an apparent dose dependency in the depression. On 
this basis, it has been proposed that bone marrow examinations 
performed promptly after an assumed exposure and at daily 
intervals for a period of one week would be most useful in 
detecting exposure to radiation in the 0.5 - 3 Gy range (Cronkite, 
1966). 
6. Cytogenic indicators 
6.1 Chromosome aberration analysis 
A more specific approach for estimating dose to humans was developed 
in the 1960s and involves culturing lymphocytes (Moorhead et al., 1960) 
and subsequently determining changes present in their chromosomes 
(Bender and Gooch, 1962; Bender 1964). Since then, many studies in 
animals and man have been performed, whereby this technique has been 
validated as a method for dose estimation in cases of whole body 
exposure (Biological Indicators Working Group Report, 1991 ). 
Chromosome changes appear dose-dependent from doses of 0.15 Gy for 
gamma-rays (0.05 Gy for neutrons) to lethal dose values. 
Various researchers employ slightly different preparative techniques. 
Lymphocytes, are separated from whole blood by centrifugation, 
stimulated by the drug, phytohaemagglutinin, to become actively dividing 
cells, and are arrested during their first division by another drug, 
colcemid. This procedure takes approximately 2 days during which 
period the cells are maintained at 370c in a mixture of culture medium 
and serum. After 48 h the cells are fixed, dispersed onto slides, stained 
and examined through a conventional light microscope for chromosome 
damage. Usually, for statistical reasons, several hundred cells need to be 
scored. 
Chromosome analysis after radiation exposure produces highly 
reproducible results which are very closely related to the dose. The 
technique has a number of disadvantages, as detailed below : 
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(a) Large inter-laboratory variations in the relationship 
between radiation dose and number of chromosome 
aberrations, (Lloyd et al., 1987). 
(b) Chromosome analysis is a labour intensive technique 
and not readily applicable when it comes to 
evaluating a large number of victims. 
(c) Nonuniform exposure presents somewhat of a 
challenge in terms of resolving the question of how to 
improve the cytogenetic dosimetry in this situation. 
However, recent developments such as the introduction of different 
staining techniques, research into automated analysis and flow cytometry 
and a better understanding of the kinetics of human lymphocytes 
suggests that chromosome analysis for radiation dosimetry will be further 
refined. 
6.2. The nucleoid sedimentation technique 
This technique is also based on induced chromosome damage in 
peripheral lymphocytes. The induced damage is evaluated by nucleoid 
sedimentation. 
This method is based on the gentle lysis of cells in the presence of non-
ionic detergents and high salt concentrations resulting in the release of 
protein (histone) depleted nuclei. The extraction of histones from the 
nuclei causes the DNA and nuclear matrix to collapse into compact 
structures called nucleoids. Nucleoids are therefore DNA 
superstructures, containing all the nuclear RNA and DNA, but no 
histones. The degree of chromosome change is reflected by alterations in 
the sedimentation co-efficient of the nucleoids. 
It was established that the nucleoid density as well as the corresponding 
sedimentation rate gradually decreases as radiation induced strand 
breaks increases (Cook and Brazell 1976, Fillippovich et al., 1982, van 
Ransburg 1987). 
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Doses as low as 0.05 Gy have been estimated, which entails 
approximately one single-strand break per chromosome (Rydberg 1984). 
It is the most sensitive of commonly used methods for quantitating DNA 
strand breakage, although it has been suggested to be too complicated 
for practical use (Cook and Brazell 1976 and Pitout et al., 1982). 
6.3 Enumeration of micronucleated erythrocytes in peripheral blood 
The occurrence of nucleated red cells in the peripheral blood following 
irradiation does not have a ready explanation (Ingram, 1960; Ingram and 
Preston, 1964). Dose~response experiments show a significant increase 
in the micronucleated erythrocytes in bone marrow and peripheral blood 
of mice with exposures as low as 0.01 Gy. It was found that in the low-
dose region (0.02 Gy) the relevant dose-response is approximately linear. 
(Grawe et al., 1992). 
With the advent of automated techniques for quantitative cytometric 
measurements, based on flow cytometry, methods for automated 
enumeration of micronucleated erythrocytes have been described, (Hutter 
and Stohr 1982). By applying these methods it may be feasible to use the 
observed increase in nucleated erythrocytes in peripheral blood as a 
parameter for estimating radiation dose. 
6.4 Assessment of micronuclei 
In addition to chromosome aberrations, radiation causes deletions which 
are responsible for acentric chromosomal fragments generally called 
micronuclei. They are observed in the cytoplasm of interphase cells 
which have passed through at least one cycle of mitosis after irradiation. 
Quantitative relationships between radiation doses and micronuclei yields 
were reported for the first time by Countryman and Heddie (1976). Since 
then a number of researchers (reviewed by Almassay et al., 1987) have 
suggested counting micronuclei in blood lymphocytes as an alternative to 
counting chromosome aberrations. 
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The reliability of conventional micronucleus assays is diminished owing to 
the inclusion of non-dividing cells in the estimate. This problem has, 
however, been overcome by the development of the cytokinesis-block 
method (Fenech and Morley 1985, 1986). These authors incubated 
proliferation-stimulated lymphocytes with cytochalasin B in such a 
concentration that karyokinesis can take place but cytokinesis is inhibited. 
By scoring binucleate cells only, analysis is restricted to those cells that 
have undergone only one mitotic division of the cell nucleus. 
The micronucleus assay circumvents some of the problems of 
chromosome dosimetry. Microscopic examination is simpler, quicker and 
therefore more cost-effective, and also may be easier to automate. This 
technique and the associated statistical analysis will be described in 




RADIATION INDUCED MICRONUCLEI IN BLOOD 
LYMPHOCYTES: IN VITRO TECHNIQUE 
1. Introduction 
The scientific and medical response to accidental overexposure to 
ionising radiation should include an attempt to estimate absorbed doses 
to irradiated persons. This information may be gained from physical and 
biological methods, although as stated before, in many situations 
information from physical techniques may be scant. At Chernobyl, for 
example, the initial sorting of casualties was done by observations of the 
speed of onset and severity of the prodromal response. More precise 
biological dosimetry was then performed using the well established 
technique of analysing peripheral blood lymphocytes for dicentric 
chromosomal aberrations. In the event of another Chernobyl-like 
accident, chromosomal studies would probably again be the method of 
choice for biological dosimetry. 
However, as chromosomal analysis is particularly labour intensive, time 
consuming and needs experienced manpower there may be 
considerable logistical problems in dealing with large numbers of 
patients. The newer micronucleus assay that utilises cytochalasin B to 
block cytokinesis offers an alternative to scoring for dicentrics. Because 
the images are far simpler, the analysis time could be completed 
significantly faster and by less skilled technicians. 
2. Objective 
The initial experiments were conducted to ensure that the micronuclei 
frequencies observed for blood samples irradiated in vitro were 
compatible with those reported by other investigators and particularly 
those previously obtained at the National Accelerator Centre (NAC), 
situated at Faure, South Africa (Slabbert, 1993). This was considered 
necessary to confirm that the experimental protocol and assessment 
criteria for micronuclei in vivo (which will be dealt with in Chapter VI) 
would concur in all respects with that used in the in vitro technique. 
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Only consistency of the assay would provide sufficient accuracy to allow 
a valid intercomparison between the in vitro and in vivo results. 
3. Experimental protocol 
3.1 Donors of lymphocytes 
To evaluate the accuracy of dose assessment by means of the 
cytokinesis blocking (CB) micronucleus assay, a systematic study was 
performed of the in vitro dose response of gamma-ray induced 
micronuclei for a selected group of healthy donors. This group 
consisted of 4 persons ages 28, 30, 37 and 57 years randomly selected 
from a heterogeneous working population. The donors were all non-
smoking, non-drinking male volunteers. Blood was obtained only once 
from each donor. 
3.2 Radiation source 
For exposure of the blood samples obtained from the donors to gamma 
radiation a modified Siemens 6DCo radiotherapy unit was used. This 
unit, shown in Fig 4.1, contains a cobalt source which has decayed to an 
activity of 70.3 TBq. The beam was directed vertically upwards. The 
dose rate was measured with a Baldwin Farmer dosimeter at a source to 
object distance of 32.4 cm, and was found to be, 88.63 cGy min-1. The 
measurement was done with a 6 mm thick perspex plate in the beam. 
The blood samples were exposed in thin wall glass tubes with an 
external diameter of 9 mm placed in a circular radiation field of 15 cm 
diameter on the perspex plate, so as to ensure electron equilibrium 
within the samples. The dose response relationship was determined in 
the dose range 1 to 4 Gy. 
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Fig 4. 1. 6°Co lrradiator 
3.3 Materials and methods 
Five heparinized whole blood samples of 10 ml each, were drawn from 
the donors. One sample of each donor served as a control for 
determining the spontaneous micronucleus frequency. The other 
samples were exposed to the 6°Co gamma-ray source. Doses of 1,2,3 
and 4 Gy were delivered at a constant dose rate to the four samples 
respectively. After exposure, the temperature of the blood was 
maintained for a further 1 h at 370c and then allowed to fall to room 
temperature. 
3.3.1 Lymphocyte separation 
Following methods by Fenech and Morley (1985), samples were 
prepared for culture by first separating the lymphocyte population from 
the other blood elements. After the blood samples were centrifuged for 
1 O minutes at 190g the serum was partially removed so that only 1 cm of 
serum remained above the cell components. 
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The remaining cells and serum were diluted (1 : 1) with phosphate 
buffered s-aline (PBS) and layered on 3 ml Histopaque (Sigma). The 
layers were then centrifuged for 30 minutes at 190g. Following 
centrifugation, the lymphocyte layer was clearly visible, and the 
supernatant was removed so that about 1 cm remained above the cloud 
of lymphocytes. Using a Pasteur pipette, the lymphocytes were 
selectively transferred to a clean centrifuge tube, diluted with an equal 
volume of PBS and centrifuged for 10 minutes at 190g. The supernatant 
was discarded and the button of cells, resuspended in 10 ml RPMl-1640 
growth medium supplemented with penicillin (0.1 mg/ml) streptomycin 
(0.1 mg/ml) and 15% heat inactivated foetal calf serum. 
3.3.2 Cell Culture 
The isolated lymphocytes were stimulated to divide by adding 100 µI of a 
1.3 mg/ml solution of phytohaemaglutinin (PHA) to the growth medium. 
The cells were incubated in an upright 25 cm2 Falcon tissue culture flask 
at 37°C. After 44 hours of incubation, cytochalasin B at a concentration 
of 3 µg/ml was added to the growth medium to block cytokinesis. The 
cultures were then incubated for an additional 28 hours. 
3.3.3 Cell Harvest 
After 72 h the cell suspensions were removed from the incubator and 
centrifuged at 93.2g for 5 minutes. All but 0.5 ml of the supernatant was 
removed and the lymphocytes resuspended in the remaining medium 
using a vortex mixer. About 10 drops of the cell concentrate were 
placed on a microscope slide which was then centrifuged for 7 minutes 
at 93.2g. Because a cytospin was not available, the slides were placed 
on filter paper at the bottom of the centrifuge bucket (Heraeus Christ, 
Digifuge model). The slides were left to dry on the laboratory bench 
after which the lymphocytes were fixed by flooding the slides with 
methanol:acetic acid (3: 1 ). 
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3.3.4 Nuclear staining 
The lymphocytes were stained with acridine orange for fluorescence 
microscopy. The staining solution consisted of 0.5 ml of a 0.1g/100 ml 
solution of acridine orange diluted in 50 ml phosphate buffer {pH 6.8). 
Slide preparations were left in this solution for 3 minutes, washed in 
distilled water and then destained for 2 minutes in the phosphate buffer 
{pH 6.8). A coverslip was mounted on a thin layer of phosphate buffer 
and the sides of the coverslip were sealed using Entellan (Merck). 
3.3.5 Scoring of micronuclei 
Fluorescence microscopy was performed using a Zeiss microscope, 
model IM 35. The microscope was fitted with a blue epi-fluorescence 
exciter filter (450-490 nm) and a 520 nm barrier filter. 
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Micronuclei were scored in binucleated cells only, using a 400 x 
magnification. Some observations were also made using a 100 x 
objective ( oil) giving a final magnification of 1000 x in cases of 
uncertainty. Binucleated cells in cell groups required particularly careful 
visual examination of the individual cell boundaries of cytoplasm. 
An average of 500 binucleate cells for any data point were scored, with a 
minimum of 449 and a maximum of 1236 cells, depending on the 
frequency of binucleate cells. 
4. Identification of micronuclei in human lymphocytes 
4.1 Criteria for the identification of micronuclei 
The criteria for scoring micronuclei in human lymphocytes were largely 
based on the rules prescribed by Countryman and Heddie (1976), 
Krepinsky and Heddie (1983), Lasne et al., (1984) and Almassy et al., 
(1987). Using fluorescence microscopy, the following standards were 
adhered to, namely : 
(a) Micronuclei were scored only in cells containing two main 
nuclei with a well preserved cytoplasm. 
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(b) A micronucleus must have the same granular structure as 
the main nucleus, i.e.the staining intensity should be equal 
to that of a main nucleus. 
(c) A micronucleus must be smaller than the main nucleus and 
must not exceed about one third of the size of the main 
nucleus. 
( d) A micronucleus must be a round or nearly round body 
visibly separated from the main nucleus. 
(e) Cells with more than two main nuclei were excluded from 
the count. These cells have been reported to consitute 
less than 5% of the population (Gantenberg et al., 1991 ), 
although they frequently contain a micronucleus. 
(f) A micronucleus must show a DNA-specific reaction, similar 
to that of the main nuclei, i.e. the green-yellow 
fluorescence with the acridine orange fluorochrome used 
for these observations (Hayashi et al., 1983) should be the 
same. 
(g) Micronuclei touching, but not overlapping each other or a 
main nucleus were counted (Huber et al., 1992). 
4.2 Observation of micronuclei 
In the cytokinesis-block (CB) method, enumeration of micronuclei is 
restricted to cells that are blocked from undergoing cytokinesis and 
which are consequently easily recognisable as large binucleate cells. 
CB cells were found to be at an ideal stage for scoring micronuclei 
because they are certain to have divided and micronuclei can still be 
easily recognised. The levels of CB cells accumulated depend on the 
proportion of cells in culture that respond to mitogen but it is generally 
possible to accumulate several hundred CB cells from a 1 ml culture. 
Huber et al., (1983) claimed that the conventional micronucleus assay 
as applied to lymphocyte cultures was too imprecise to detect exposures 
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to x-ray doses less than 30 cGy. By contrast, the results obtained by 
Fenech and Morley (1986) indicate that exposures to 5 cGy of x-rays are 
readily detected by the CB method and that such detection can be done 
rapidly because hundreds of CB cells can be visually scored within a few 
hours. 
Fig 4.2 Photomicrograph of a binucleate lymphocyte 
containing micronuclei 
5. Results 
The dose response data obtained by scoring micronuclei in CB cells of 4 
donors are summarized in Table 4.1. The Poisson standard errors are 
given in brackets. Included in the table is the percentage of binucleated 
cells (BNC) observed in each culture. 
The consistency of yield between donors at each dose was checked. In 
contrast to the extensive interindividual variability noted by Gantenberg 
et al., 1991 and others, the present data was found to be in very good 
agreement. It was therefore considered reasonable to pool the data. By 
averaging the mean yields of each donor the data in Table 4.2 was 
obtained. 
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Table 4. 1: Mean micronuclei (MN) frequencies observed in cytokinesis 
blocked (CB) lymphocytes following exposure to Co-60 gamma-rays, with 
standard errors given in parenthesis 





(Gv) observed 500BNC 
0 1126 13 5.8 (±1.6) 
1 470 36 38.3 (±4.5) 
2 1011 199 98.4 (±7.0) 
3 1087 279 128.3 (±7.7) 
4 1236 448 181.2 (±8.6) 
0 988 10 5.1 (±1 .6) 
1 644 67 50.5 (±6.2) 
2 484 86 88.8 (±6.8) 
3 690 205 148.6 (10.4) 
4 1006 347 172.5 (±9.3) 
0 449 6 6.7 (±7.7) 
1 538 41 38.1 (±6.0) 
2 871 192 110.2 (±8.0) 
3 689 188 136.4 (±9.8) 
4 704 269 191.5 (11.6) 
0 696 11 7.9 (±2.4) 
1 1232 109 44.2 (±4.2) 
2 971 155 79.8 (±6.4) 
3 655 185 141.2 (10.4) 
4 574 234 203.8 (13.3) 
Table 4.2: Mean values of pooled data given in Table 4.1, 






















Dose (Gy) 0 1 2 3 4 
Mean MN 1.24 E-2 8.56 E -2 1.88 E-1 2 .75E-1 3.69 E-1 
per BNC (± 1.8 E- 3) (± 9.8 E - 3) (± 2.3 E -2) (± 1.6 E -2) (± 2.2 E -2) 
A linear relationship appears evident between dose and mean 
micronuclei frequency. Consequently, as a first approach, and in 
accordance with previous work (Slabbert, 1993) linear-regression fitting 
was done. The analytical expression of the linear-regression fit to these 
data, represented in Fig 4.3 by the solid line, is given by: 
53 
y = 9.022E-2 (± 2.326E-3)0 + 5.482E-3 (± 5.698E-3) 
with r2 = 0.998 
(Equ 4.1) 
Whilst there is no difficulty in deriving a dose from a measured yield of 
micronuclei, there is no generally accepted way of deriving its 
uncertainty. The uncertainty is usually expressed as a 95% confidence 
interval, which defines an interval such that the limits will encompass the 
true dose on 95% of the occasions. 
0.45 T 
oo~f ~~ 
[oo~f ~ .. /// 
! o:: I .· ..  · .. ···:::::::: ::::::::::_. __ .,..,.-------
0.1 1 ......... ., .. / 
0 051 . . .... ············· .. , .. /··'/ 
. I .... ··· .. ,··' 
f . ,. .. ,··' 
o r·· ,·· 
-0.05 ~ 3 
Fig 4.3: Dose response curve fitted by linear regression. 
(95% confidence intervals are given by the broken lines) 
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In the regression fitting equal weights were given to each point. At the 
lower doses i.e. at O and 1 Gy, there appears to be more marked 
differences between the observed and calculated values of the number 
of micronuclei per binucleate cell than at the high doses. It might be 
suggested that low dose points should be weighted more than high dose 
points. 
The data were then fitted by an iteratively reweighted least squares 
method using a 486 personal computer and a statist ical software 
package, SAS/STAT. The program gives the maximum likelihood 
estimates of the parameters exactly. This method, described by 
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Papworth (1975) has been used extensively by others (Lloyd et al., 
1987; Balasem et al., 1993 etc.) in this regard. 
The average yields of MN and their distribution in BNC from irradiated 
blood samples of the 4 donors are shown in Table 4.3. To test whether 
the distribution was Poissonian, Papworth's U test was used (Papworth, 
1970). 
The variance is given as : 
Nj 
cr2 = :E (kj - y)2/(Nj - 1) 
t = 1 
(Equ 4.2) 
where ki is the number of micronuclei in the t th of N cells (Huber et al., 
1992). The ratio is cr2/y known as the dispersion index, where y is the 
mean micronuclei frequency. Over dispersion is indicated when cr2/y is 
greater than unity. 
To determine if the mean and the variance of the observed distributions 
were significantly different, the standard unit normal deviate of (cr2/y) 
(µ-parameter in Table 4.3) was calculated according to Savage (1970). 
µ = d - (N - 1) / -V2(N - 1 )(1 - 1 / Ny) (Equ 4.3) 
where d = (N -1) cr2/y (coefficient of dispersion) 
Over dispersion is indicated by a positive value of µ, and under 
dispersion by a negative value. Ifµ exceeds 1.96 the over dispersion is 
significant at the 95% confidence level, which means that with a Poisson 
distribution there is only a one in 20 chance that the magnitude of µ will 
exceed 1.96. 
The observed distributions of micronuclei deviated from a Poissonian 
distribution; they were significantly over dispersed for all the donors 
except at the zero dose values (Table 4.3). 
Radiation induced micronuclei in general tend to exhibit an over 
dispersed distribution even for an homogeneous exposure, whereas 
dicentric chromosome aberrations tend to show a Poissonian distribution 
(Prosser et al., 1989). 
55 
Table 4.3: Intracellular distribution of MN in CB cells (Micronuclei frequencies 









CB cells MN distribution in CB cells cr2ly µ 
observed 
0 1 2 3 4 5 6 
3259 3219 40 - - - - - 0.987 -0.489 
2904 2678 200 25 1 - - - 1.13 5.14 
3337 2867 348 87 30 5 - - 1.46 19.05 
3121 2435 552 104 23 7 - - 1.23 8.99 
3520 2527 756 191 30 10 6 - 1.25 10.47 
The way in which this over dispersion was taken into account when the 
data were fitted to a curve by iteratively reweighted least squares is as 
follows. There seems to be no systematic change of variance with dose 
although the zero point could be regarded as showing a Poissonion 
distribution. It can be assumed that the variance/mean ratio is 
independent of dose and averages 1.2. The Poisson standard errors 
are then increased by .../1 .2 for all points and this is included when 
weighting factors are calculated. The weighting factors used were 11cr2. 
As expected this analysis indicates a polynomial of the first degree of 
which the analytical expression, represented by the solid line in Fig 
4.4(a), is given by the equation: 
y = 8. 73E-2(±2.68E-3)0 + 1.14E-2 (2.6E-3) 
with a probability, p = 0.1231 
(Equ 4.4) 
Alternatively one could say that the Poisson distribution applies at zero 
dose and the variance to mean micronuclei frequency ratio is 1.25 at all 
other doses. This leads to the dose-response relationship represented 
by the solid line in Fig 4.4 (b) for which the following equation applies: 
y = 8. 72E-2(±2.66E-3) 0 + 1.16E-2(2.36E-3) 
with p = 0.1337 
(Equ 4.5) 
In both figures 4.4(a) and (b) the 95% confidence limits are indicated by 
the broken lines. 
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Both methods result in very similar fits to the data. The fit to a straight 
line is very good, particularly in view of the large number of micronuclei 
scored at high doses. 
The method of calculation of standard errors for the curves comes 
directly from the reweighted least squares fitting routine (SAS/STAT 
software package). A routine which fits data using orthogonal 
polynomials was used. The standard errors on the coefficients of the 
orthogonal polynomials were supplied by the program and these were 
combined assuming independence, to obtain the standard errors on the 
coefficients and on the curves. The standard errors are based on a 
variance which is calculated using the deviations of the points from the 
fitted curve. 
6. Discussion 
There is very little difference between the curves illustrated in Figs 4.3 
and 4.4. However, in theory the reweighted least squares analysis 
should provide a more accurate fit to the observed data than the linear -
regression procedure. 
Despite the fact that there is also little to choose between the dose-
response curves obtained by the above analysis it was decided to utilise 
the dose-response curve given in Fig 4.4(b) for later calculations of 
estimated dose. The reasons for this choice are the following: 
(a) The assumption that the Poisson distribution applies at 
zero dose was verified for all the individual donors and 
was also found consistently in the results of other 
researchers. (Lloyd et al., 1991 ). 
(b) The predicted zero dose value obtained by the second analysis 
(Fig. 4.4 (b)), 1.16E-2 (±2.36E-3), appears to be a better estimate of 
the observed value of 1.24E-2 (± 1.BE-3). 
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7. Comparison of dose-response relationships 
There are numerous descriptions of dose-response relationships with 
micronuclei as end-point described in the literature. Since the studies of 
Evans et.al. (1959) many authors have shown that radiation induced 
micronuclei in stimulated peripheral blood lymphocytes is a sensitive 
biological indicator of chromosomal damage (Countryman and Heddie, 
1976; Fenech and Morley, 1985; Huber et al., 1983; Pincu et al., 1984; 
Ramalho et al., 1988). However, comparing the type of dose-effect 
relationships reported in the literature extensive interlaboratory 
differences appear. 
The relationships have been described as linear (Huber et al., 1983; 
Bauchinger, 1984; Pincu et al., 1984; Fenech et al., 1985; Fenech et al., 
1986; Fenech et al., 1989; Fenech et al., 1990; Balasem et al., 1992 and 
Slabbert 1993.), linear-quadratic (Bettega et al., 1980; Huber et al., 
1983; Krepinsky and Heddie, 1983; Almassy et al., 1986 a,b; Almassy et 
al., 1987; Kormos and Koteles, 1988; Prosser et al., 1989; Littlefield et 
al., 1989 and Gantenberg et al., 1991 ), or conforming to a power-law 
expression (Countryman and Heddie, 1976). 
Prosser et al. (1988) have demonstrated, what may be seen as a 
compromise, i.e. that up to 1 Gy of exposure the frequency of induction 
of micronuclei is linear-quadratic and beyond 1 Gy it remains virtually 
linear. 
The results of the various workers can be compared to assess the 
suitability and relative accuracy of dose assessment using this 
technique. When these different relationships are translated 
mathematically to the absolute number of micronuclei induced per unit 
dose, differences up to a factor of two or more appear. Moreover, the 
response seemed to vary with the type of radiation and the time of 
culturing (Huber et al., 1983). 
A disturbing feature was the difference in micronuclei yields reported by 
two laboratories that shared aliquots of the same samples of blood 
(Lloyd et al., 1991 ). lnterlaboratory disagreements apparently resulted 
from differences in technical procedures and different criteria for the 
identification of micronuclei. 
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Several research groups report that an increase of donor age resulted in 
an increase of the spontaneous incidence of micronuclei (Fenech and 
Morley, 1986; Huber et al., 1989), which could also be partly responsible 
for the observed difference in micronuclei yield. Thierens et al. (1991) 
stated unequivocally that the low accuracy of the dose assessment in 
the dose range up to 1 Gy and the detection limit of 30 cGy, in this range 
could be attributed to the poor statistics for the number of micronuclei 
and to the variability of the spontaneous incidence of micronuclei within 
a heterogeneous population. This phenomenon would only make a 
difference in the very low levels of the yield of micronuclei induced by 
relatively low doses of radiation, but will hardly be of any importance 
with doses expected in screening programs following a radiation 
incidence exceeding 1 Gy. 
The above authors came to the conclusion that a higher degree of 
international co-operation and standardisation of the CB micronucleus 
assay was required to eliminate the reported differences. Attempts in 
this regard had been made earlier, for example, by substituting 
microscopic observation with flow cytometric analysis (Nusse and 
Kramer, 1984) and computerised image analysis (Callisen et al, 1984). 
It was expected that automation would reduce statistical uncertainty, and 
also improve the sensitivity of the micronucleus test, simply because of 
the possibility of screening many thousands of cells in a very short time. 
By scoring for instance 4000 - 5000 cells, Fenech and Morley (1986) 
showed that doses as low as 5 cGy could be detected with this 
technique. 
Despite the fact that efforts to standardise the technique were started 
more than a decade ago, the differences in the results of more recent 
studies still point to the need that interpretation of micronuclei yields in 
terms of dose should be done using in vitro calibration curves 
constructed in the same laboratory where the dose determination is to 
be done. 
In more recent studies (similar to the present one) the linear dose-effect 
relationship was confirmed, which is in contrast to the linear-quadratic 
relationship usually observed for chromosome-type aberrations (IAEA, 
1986). Consequently it was decided to compare some of the available 
linear dose-response data obtained with similar experimental protocols, 
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to that of the present one, with the results obtained in this study. For 
this purpose data given by the following authors were used, namely 
Fenech et al. (1985); Fenech et al. (1986); Fenech (1989); Balasem et 
al. (1992); and Slabbert et al. (1993). The data was first mathematically 
translated to induced micronuclei per 500 CB cells for different exposure 
values in cGy. 
Linear-regression analysis of these data indicated that the relationships 
could be described by the following equations: 
y=0.50 (±0.20)0 - 0.28 (±3.27) with r2 = 0.97 Fenech et al. (1985) 
y=0.40 (±0.03) D + 4.85 (±0.58) with r2 = 0.88 Fenech et al. (1986) 
y=0.38 (± 0.05) D + 24.84 (± 10.43) with r2 = 0.61 Fenech et al. (1989) 
y=1.1 O (± 0.02) D + 6.39 (±0.32) with r2 = 0.99 Balasem et al.( 1992) 
y= 0.52 (± 0.02) D+ 4.26 (± 4.14) with r2 = 0.99 Slabbert (1993) 
y= 0.45 (± 0.01) D + 2. 7 4 (± 2.85) with r2 = 0.99 This study. 
By means of an analysis of covariance it was tested whether the six 
regression equations, based on the six different sets of data significantly 
differ from each other. In the first stage of the analysis a test was 
performed to determine if the regression coefficients differ significantly, 
and it was found that the null-hypothesis of equal regression coefficients 
could not be discarded at a 5% significance level. 
In the second part of the analysis a common gradient was assumed and 
a test was performed to determine if the y- intercepts differ significantly. 
Once again the null-hypothesis could not be discarded (p < 0.05). 
Because of the generally poor statistics at low doses the results of curve 
fitting sometimes lead to negative estimates of the background value 
which obviously have no biological basis. Opinions vary as how to treat 
the background level of micronuclei in fitting dose response data. Some 
investigators resolve this problem by ignoring zero-dose data points and 
constraining the curve to pass through the origin. There are, however, 
sufficient data published from surveys of subjects exposed only to 
background radiation to show that there is a marked positive background 
level of micronuclei. Ideally a laboratory should generate its own 
background data. 
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In conclusion, however, it may be considered that all six regression lines 
are in fact representative of the same universal set. In view of the 
diversity in the dose-response relationship (measured in terms of 
micronuclei induced in CB cells) described in the literature, it was 
reassuring to find agreement between six different sets of data. The 
induced micronuclei frequency determined in this study could therefore 
be substituted with confidence in the equations for calculating the 
radiation dose equivalent due to partial body irradiation, which will be 




PHYSICAL ESTIMATE OF THE EQUIVALENT WHOLE-BODY DOSE 
OF DONOR PATIENTS FOLLOWING FRACTIONATED PARTIAL-BODY 
RADIOTHERAPY 
1. Introduction 
Experience over more than 25 years has shown that most suspected 
overexposure incidents have involved just one, or occasionally a few 
subjects, usually inhomogeneously exposed. Such incidents involve 
either chronic or fractionated exposure. When considering the use of 
MN evaluations as a tool for biological dosimetry this as well as the 
question whether there are any differences between the dose-response 
relationships after in vitro and in vivo exposure of lymphocytes, should 
be considered. 
Since there is no significant difference between the dose-response 
curve for chromosome aberrations in lymphocytes obtained following in 
vivo whole-body irradiation and that obtained following in vitro irradiation 
of lymphocytes (Buckton et al., 1971; Clemenger and Scott, 1971 and 
Fabry and Lemaire, 1986) it is reasonable to expect the same for 
micronuclei which are derived from chromosomal aberrations. 
Gantenberg et al. (1991) found that there was indeed no statistically 
significant difference between in vitro and in vivo results obtained with 
MN. However, the results observed for whole-body irradiation do not 
necessarily apply to fractionated partial-body exposures. In the latter 
case there is usually sufficient time between radiation fractions for the 
lymphocytes to redistribute themselves either within or outside the 
radiation field, which could influence the distribution of damage within 
the lymphocyte pool. This and other considerations such as interphase 
cell death, have to be taken into account in applying the cytokinesis-
blocked (CB) micronucleus assay for dosimetric purposes. 
Although several laboratories have reported data on in vitro MN dose 
response, there have been few reports of MN evaluations in persons 
who have received radiation exposure (Fenech et al., 1990). In these in 
vitro experiments, for each dose, volumes of irradiated and unirradiated 
blood from the same donor were mixed in differing proportions in order 
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to simulate the mixing of blood that would occur after acute partial-body 
irradiation (Lloyd et al., 1987; Lloyd et al., 1991 and Vral et al., 1992). It 
is therefore a more simplified situation than that which applies in vivo 
where the distribution of doses over the body would form a continuum 
rather than two homogeneous fractions. The simplification also has 
taken no account of the distribution and circulation characteristics of 
lymphocytes or any other physiological processes that may operate on 
lymphocyte populations in vivo. Nevertheless, these experiments 
demonstrated that it should be possible to use biological dosimetry to 
give a more refined indication of a high, but non-uniform irradiation, over 
and above quoting an estimate of averaged equivalent whole-body dose. 
Lloyd et al. (1991) stated that in vivo studies of partially or 
inhomogeneously irradiated persons are neccessary as a follow up to 
the in vitro work on which his group reported. 
2. Objective 
The primary objective of the present work was to follow up the above-
mentioned recommendation of Lloyd and his co-workers (1991 ). For this 
accurate physical dosimetry of the irradiated persons is necessary, to 
calculate an equivalent whole-body dose which could serve as reference 
to determine the validity of the biological measurements. Consequently 
the first objective was to determine integral doses to irradiated sites from 
computer-derived dose-volume histograms, and to use these doses to 
calculate the appropriate equivalent whole-body doses. 
3. Selection of Patients 
To evaluate the use of the CB micronucleus method for radiation 
dosimetery following in vivo exposure of lymphocytes, a similar study 
was designed to that described by Buckton (1983) for irradiated 
ankylosing spondylitis patients. The main difference between the 
present study and that of Buckton (1983) was that the patients had a 
variety of tumour sites and integral doses. 
The project was approved by the Ethics Committee of Tygerberg 
Hospital and the informed consent of each individual patient selected 
was obtained. 
Eight patients with different types of cancer were studied prospectively. 
As a first approach it was decided to perform the MN assay on 2 patients 
who received a single-dose of half-body irradiation. This would exclude 
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complications for which dose fractionation could possibly be responsible 
and should provide an equivalent whole-body dose of approximately 3 to 
4Gy. 
Two patients treated for multiple metastases of prostate cancer were 
selected. It was not possible to find a sufficient number of binucleated 
cells for assay in lymphocyte cultures of blood samples obtained from 
these patients after exposure. This was probably due to prior treatment 
and medication that accompanied half-body irradiation of the patients 
(see Chapter VI). 
Six patients with cancer undergoing fractionated partial-body irradiation 
were therefore selected on the following basis : 
(a) that they had not undergone any previous radio- or 
chemotherapy; 
(b) to represent relatively large irradiated volumes and consequently 
a wide range of integral doses; 
(c) that they would survive treatment; and 
(d) that the treatment plan consists of single planar fields. 
In four patients conventional radiotherapy was carried out according to a 
standard protocol of fractionated daily irradiation over a period of 5 to 6 
weeks. It was planned to collect blood samples just before radiation 
treatment, 24 h after completion of the first treatment and thereafter once 
weekly for 4 consecutive weeks during treatment. The experimental 
protocol was limited, to the first 4 weeks of treatment, because beyond 4 
weeks of treatment, patients may receive a blood transfusion and/or, the 
treatment plans are modified, due to tumour shrinkage. 
Two patients were planned to receive palliative treatment, in 3 fractions 
over a period of 3 weeks. It was not possible to uphold the treatment 
protocol for these patients because both of them died within a few days 
after receiving the first dose fraction. However, the single blood 
samples obtained from both of these, 24 h after the first treatment, · is 
nevertheless of importance for the previously mentioned refined 
calculations regarding partial-body exposure ( see Chapter VI section 
3.2). 
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4. Details regarding individual patients 
In the following sections the relevant clinical history, treatment plans and 
other details regarding the radiation treatment of the individual donor 
patients are given. 
4.1 Patient : a 
This patient was treated for cancer of the prostate with a 16 MV linear 
accelerator. A total tumour dose of 64 Gy was given in 32 fractions at a 
dose rate of 2.5 Gy min-1. The treatment plan included 4 radiation fields 
as indicated in Fig 5.1 . 
4.2 Patient : b 
This patient had stage 38 cancer of the cervix and was given a total 
tumour dose of 50 Gy with a 8 MV linear accelerator. The dose was 
administered in 25 fractions at a dose rate of 2.2 Gy min-1. The 
treatment plan was a combination of 4 radiation fields as indicated in 
Fig 5.2. 
4.3 Patient : c 
This patient received treatment for a carcinoma of the bladder. A total 
dose of 59.4 Gy was given in 31 fractions at a dose rate of 2.2 Gy min-1. 
The treatment is the product of four 8 MV photon beams as illustrated in 
Fig 5.3. This patient received a blood transfusion and the treatment plan 
was also modified at the end of the fourth week of treatment, however 
the last blood sample was collected before the blood transfusion. 
4.4 Patient: d 
This patient was treated for a stage 38 cancer of the cervix. · A total 
tumour dose of 50 Gy was administered in 25 fractions at a dose rate of 
2.5 Gy min-1. A combination of four 16 MV photon beams were used, as 
indicated in Fig 5.4. 
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4.5 Patients : e and f 
Both these patients were treated for cancer of the cervix, stages 38 and 
4A respectively. They were treated with a Co-60 unit delivering a dose 
rate of 0.921 Gy min-1. In both cases two direct opposing fields were 
used [(13 x 13) cm with a separation of 19 cm, and (14 x 13) cm with a 
separation of 20 cm respectively] as illustrated in Fig 5.5. The total 
tumour dose of 30 Gy was to be given in three equal weekly fractions of 
10 Gy each. 
5. Dose-volume histograms (DVH) 
Significant development has occurred in the technology of treatment 
planning in recent years. From central axis isodose curve distributions 
providing single planar treatment plans in the past, the spectrum of 
available dosimetry modalities has grown to include a number of 
techniques which directly produce three-dimensional (30) dosimetric 
maps tailored specifically to the research task at hand. 
One such an alternative method to isodose distributions of displaying the 
results of dose calculations, is by the use of dose-volume histograms. 
Treatment plans represent dose calculations in a single plane whereas 
dose-volume histograms require dose calculations in three dimensions. 
Although the latter do not replace isodose distributions, they are very 
useful when used in conjunction with them, particularly when comparing 
different treatment plans for the same patient. A drawback is that they 
are very time consuming to calculate. 
A histogram may be plotted according to the usual mathematical 
definition, as the accumulated volume of those elements receiving dose 
in a specified dose interval against a set of equispaced dose intervals. 
This is referred to as a differential dose-volume histogram (DVH). Such 
a DVH graphically summarizes the simulated radiation distribution within 
a volume of interest, or within the total irradiated volume of a patient, 
which would result from a proposed radiation treatment plan. In most 
instances, the volume is specified as the percentage of total volume 
receiving dose within each percentage dose interval; however, it may be 
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The use of DVHs as well as details of methods for their calculation has 
been described in the literature (Chen et al., 1984; Drzymala et al., 
1987; Lyman, 1985; Mohan et al., 1987; Kooy et al., 1993; Webb, 
1993.) 
5.1 Method for generating and plotting DVHs 
Initially, the boundaries of the relevant anatomical structure of the 
patient must be defined and the dose must be computed for the volume 
of interest (usually the tumour). The relevant anatomy is then 
subdivided into a volume grid of appropriate resolution. To arrive at the 
total volume of this anatomy or the volume of a particular structure within 
this anatomy, the relevant volume elements (voxels) are summed. 
Concurrently with voxel-summing the dose for each voxel can be 
determined so that, ultimately all contributing voxels are accumulated 
within the appropriate dose bin of the histogram. The bin values are 
then plotted. 
5.2 Three-dimensional representation of the patient 
The basic anatomical representation of the patient is provided by a 
contiguous sequence of computed tomographic (CT) scans. This 
volume may be visualized as being subdivided into a three-dimensional 
grid of cuboid volume elements which is equispaced in the X and Y 
directions but may or may not be equispaced in the Z direction. (In the 
present study, each CT slice lies at a constant Z). The volume of a 
voxel, therefore, is the product of the X and Y grid spacings and the slab 
thickness. 
5.3 Computational accuracy 
Computing a DVH involves three-dimensional volume and radiation dose 
matrices, which need not coincide. Dose calculations tend to be slow, 
consequently a relatively coarse matrix is usually employed, but the 
matrix required for accurate volume estimation may be of much finer 
resolution. The finer the grid, the greater the accuracy of dose 
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calculation, with the disadvantage, however of increased computation 
times and the creation of large disk files. The conflicting requirement of 
computing dose in a large total treatment volume yet with sufficient 
resolution to capture dose gradients that change within millimetres 
sometimes excludes computing dose values on a regular spaced grid. 
Such a grid would require on the order of 1 os computations (10 cm3 at 
better than 0.25 cm resolution). Goitein and Miller (1983) demonstrated, 
however that 2% dose accuracy could be achieved with a grid spacing of 
5mm. 
5.4 Application of DVHs 
Dose-volume histograms can be used for comparing alternative 
treatment plans for a specific patient or as input data to estimate tumour 
control probability and normal tissue complication probability. A plot of a 
cumulative dose-volume frequency (or DVH) could, however, also be 
computed which graphically represents the total radiation distribution 
within a patient's body. Such a plot can therefore be used to calculate 
the integral dose received by the patient. 
The total energy absorbed from the beam by the patient is called the 
integral dose and was defined originally by Mayneord (1942). The 
integral dose to a mass of tissue is the product of the mass of tissue and 
the dose which it receives. Thus the unit of integral dose is the kg. Gy 
(i.e. 1 kg Gy = 1 Joule). 
The area under the DVH therefore represents the relative integral dose 
received by the patient. 
6. Physical dosimetry results 
A cumulative DVH has been computed by means of the "Target" 
(General Electric) non-coplanar radiotherapy treatment planning 
program for the total irradiated volume resulting from the treatment plan 
of each participating patient. Figures 5.6 through 5.11 are the graphic 
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It is convenient to use normalized relative values in these plots. For 
these computations X,Y and Z grid spacings of 5 mm, and dose intervals 
of 5% were used. Consequently for each histogram the dose was 
calculated at approximately 20 000 points providing an estimated dose 
accuracy of approximately 2%. 
The relative integral dose is the sum of the products of the percentages 
of the volume irradiated and the corresponding dose frequencies (i.e. 
the different percentages with the relevant interval midpoints 2.5, 7.5 ----
- 97.5 etc.). The absolute integral doses were obtained by multiplying 
these figures with total irradiated volume and the applicable tumour 
doses given in Table 5.1 
To derive an equivalent whole-body dose which could be related to dose 
estimates determined by the cytokinesis-blocked micronucleus assay for 
lymphocytes irradiated in vivo, use was made of the findings of 
Matsubara et al. ( 197 4 ). In their extensive study of partial-body 
irradiation with varying single doses of gamma rays, they reported that 
the fraction of irradiated lymphocytes could be approximated by the 
volume of the irradiated site relative to body weight. This approximation, 
has to take into account some important variables ( see 7 below). 
In the present investigation, this approximation was applied, and an 
equivalent whole-body dose estimated by dividing the integral dose by 
the body weight of the patient. Full details of the tumour doses, integral 
doses and equivalent whole-body doses are listed in Table 5.1 
7. Validity of the calculated equivalent whole-body doses 
A comparison of whole-body dose estimates based on the MN frequency 
ratio in lymphocytes following fractionated partial-body radiation therapy 
with calculated whole-body doses from physical dose measurements will 
be valid with regard to the latter, if it is assumed that : 
(a) fractionation of radiotherapy results in a significant dispersal of 
the total dose over the lymphocyte pool; 
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Table 5. 1 Physical dose calculations for donor patients 
Patient related Tumour Absolute Integral Equivalent Whole 
information Dose (Gy) Dose (kgGy) Body Dose (cGy) 
Patient a 2 3.33 4 
!Volume irradiated (cc) 6371 10 16.64 18 
Body weight (kg) 90 20 33.28 37 
Relative integral dose 2612.5 30 49.92 55 
40 66.56 74 
Patient b 2 8.21 18 
!Volume irradiated (cc) 7389 10 41.06 89 
Body weight (kg) 46.0 20 82.12 179 
Relative integral dose 5557.5 30 123.18 268 
40 164.24 358 
Patient C 2 8.57 15 
Volume irradiated (cc) 7602 12 51.43 93 
!Body weight (kg) 55.4 19.8 84.86 153 
!Relative integral dose 5637.5 28.8 123.44 223 
39.6 169.73 306 
Patient d 2 12.91 16 
!Volume irradiated (cc) 14484 12 77.47 97 
Body weight (kg) 79.5 22 142.03 179 
Relative integral dose 4457.5 32 206.59 260 
42 271.15 341 
Patient e 
!Volume irradiated (cc) 4707 10 31.70 41 
IBody weight (kg) 76.4 
Relative Integral dose 6735 
Patient f 
Volume irradiated (cc) 5221 
Body weight (kg) 81.8 
Relative integral dose 6822.5 10 35.62 44 
(b) the variation in the concentration of lymphocytes within the 
different irradiated sites of patients is not significant; and 
(c) the densities of different tissues throughout the body are the 
same. 
It must further be considered that there is also a variability in the 
proportion of lymphoid tissue and bone marrow such that the 
consequences of partial-body irradiation may be very site specific 
(Liniecki et al., 1983; Savage and Breckon, 1985). 
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Antoine et al. (1981) and Deiner et al. (1988) suggested that exposure of 
a relatively small part of the body to a single fraction out of a series of 
fractions that make up the total fractionated treatment is unlikely to result 
in a uniform exposure of all lymphocytes. However, an entire course of 
fractions would result in a relatively uniform exposure over the 
lymphocyte pool. 
With regard to the present study a further assumption is that the 
frequencies of the induced MN are independent of the photon energy 
and dose rate of the radiation inducing the MN. Although this is contrary 
to the results of some authors (Almassy et al., 1987) it seems 
reasonable to accept these assumptions because : 
(a) there is no difference between the radiation weighting factors of 
the relevant radiations used (ICRP, 1990) and 
(b) the effect of various dose rates on the frequencies of MN was 
demonstrated only with low doses administered at extremely low 




BIOLOGICAL DOSIMETRY : USING THE CYTOKINESIS BLOCKED 
MICRONUCLEUS ASSAY FOR QUANTIFYING THE DOSE TO 
RADIOTHERAPY PATIENTS WHO RECEIVED FRACTIONATED 
PARTIAL-BODY IRRADIATION 
1. Introduction 
Measurement of cytogenetic damage by simple techniques would be of 
great value in evaluating the radiation risk following fractionated partial-
body, occupational or accidental exposure in circumstances when 
physical dosimetry was not available. The reliability of the conventional 
CB micronucleus assay for this purpose has never before been proved 
unequivocally. The findings of various authors (Littlefield et al., 1991; 
Lloyd et al., 1991 and Prosser et al., 1989) suggest that in general the 
micronucleus assay does not give reliable estimates of equivalent 
whole-body dose as does chromosomal aberration analysis. 
Accidental irradiation is usually due to a single inhomogenous exposure. 
For highly irradiated patients the clinician requires information on the 
inhomogeneity of the exposure as management of casualties may 
require an early decision on whether treatment should include 
transplantation of allogenic bone marrow or treatment with growth 
factors. If there is a likelihood that some of the patient's own marrow will 
have survived because of inhomogeneous exposure, then 
transplantation should be avoided. Graft rejection was observed in 
several of the Chernobyl patients (Lloyd et al., 1991) and in some cases 
probably contributed to their deaths. 
Two methods have been proposed for analysing chromosomal 
aberration data from inhomogeneously exposed persons with the 
objective of improving the dose estimates to reflect non-uniformity, rather 
than quoting an averaged whole-body dose estimate that is obtained 
simply from relating a dicentric yield to an in vitro dose response curve. 
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The first method, known as the contaminated Poisson method was 
proposed by Dolphin (1969) and the second approach, termed the Qdr 
method, by Sasaki and Miyata (1968). It might be inferred that both 
these methods are applicable to MN data. 
However, the Qdr method is based on the ratio of unstable chromosomal 
aberrations (dicentrics and rings) consequently it is not applicable to MN 
data. The contaminated Poisson method is based on the overdispersed 
distribution of aberrations among the scored cells. This overdispersed 
distribution is considered to be the sum of a Poisson distribution which 
represents the irradiated fraction of the body and the remaining 
unexposed fraction. Micronuclei however have a natural underlying 
tendency for overdispersed distributions even with homogeneous 
irradiation. Consequently the assumption that the Poisson distribution 
applies to MN in cells which have been irradiated breaks down. 
Therefore the above methods do not unconditionally enable similar 
calculations for micronuclei as endpoints, but can possibly be modified 
to take the overdispersion into account. 
With fractionated partial-body exposure a further problem arises which 
theoretically renders the dose estimate from MN data unsuitable for 
estimating the localized dose. Between dose fractions the lymphocytes 
mix thoroughly, so that after several fractions some cells have been 
irradiated once, some twice, some three times, etc. The population of 
lymphocytes is not a simple uniformly irradiated fraction, which is the 
basic assumption made when applying the contaminated Poisson 
method (Dolphin, 1969) and the Qdr method (Sasaki and Miyata, 1968). 
2. Objectives 
The objectives of the present study were the following : 
(a) To show that MN evaluations in patients who receive 
fractionated partial-body exposures can serve as a 
qualitative biological marker of their radiation 
exposures. 
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(b) To determine whether MN analysis will yield statistically 
significant quantitative information on the radiation 
doses of these patients, with the objective of quoting 
averaged whole-body dose estimates obtained from 
relating MN yields to an in vitro dose response curve. 
(c) To attempt to confirm the findings of Gantenberg et al. 
(1991) that there is no significant difference between 
the induced MN frequencies obtained with in vitro and 
in vivo whole-body exposure respectively. 
(d) To derive a mathematical method for analysing MN 
data from persons having received a single 
inhomogeneous exposure, with the object of improving 
the dose estimates to take the fraction of the body 
irradiated and localized dose into account. 
3. Experimental protocol 
The experimental protocol was aimed to meet the objectives in 2 above 
following similar laboratory techniques as was used for the scoring of MN 
induced in vitro, as discussed in Chapter IV. 
3.1 Laboratory procedure 
Blood samples (10ml) were drawn from patients into heparinized tubes. In 
two patients receiving a single dose (6 Gy) half body exposure blood 
samples were collected before and 24 h after completion of radiation. · 
Blood samples were collected from the other six patients who were 
undergoing fractionated radiotherapy before and 24 h after their first 
exposure, and thereafter at weekly intervals for 4 weeks during the course 
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of treatment. Peripheral blood lymphocytes were isolated from the whole-
blood sample and cultured using the technique described in Chapter IV 
section 3.3.2. 
From each culture a minimum of four microscope slides were prepared and 
stained as described in sections 3.3.3 and 3.3.4 of Chapter IV. Following 
the set criteria for MN identification the MN frequency for any data point 
was determined by attempting to score at least 500 CB cells. For most of 
the data points, particularly at higher exposure values, it was necessary to 
scan all four slides to accumulate a sufficient number of CB cells. 
3.2 Methods of calculation of the dose to the irradiated body fraction and 
the volume of this fraction 
The two methods by which one may arrive at an estimate of the localized 
dose and irradiated body fraction have been reviewed in IAEA Report 260 
(1986). 
Qdr method. The Qdr method was proposed by Sasaki and Miyata 
(1968). This method assumes that all cells with unstable chromosome-type 
aberrations (dicentrics, rings and excess acentrics) were irradiated and it 
considers the ratio of dicentrics plus rings to the total number of damaged 
cells. This ratio, Q!rcan be related to dose by the following equation: 
(Equ. 6.1) 
where Y1 is the dose-response curve for dicentrics plus rings and Y2 the 
curve for total aberrations. In view of the dependance of the Qdr method 
on specific and total aberrations it is not suitable for application to MN data. 
The contaminated Poisson method. The contaminated Poisson method 
described by Dolphin (1969) considers how the observed distribution of 
dicentrics deviates from the Poisson distribution that would be expected 
from a homogeneous exposure. It assumes that a fraction (J) of the scored 
cells have received a uniform dose and thus the distribution of aberrations 
among them is Poissonian. These are mixed with a fraction (I - f) of 
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unexposed, and therefore aberration free, cells. Maximum likelihood 
estimates of f and the mean aberration yield (y) in this fraction are 
calculated by using equations 6.2 and 6.3 below. The mean dose to the 
fraction f may be obtained from y by reference to the dicentric dose-
response curve. 
y I I - e·Y = X I N - no (Equ. 6.2) 
yf = X I N (Equ. 6.3) 
where N is the number of cells scored, X the number of dicentrics scored, 
and no the number of cells free of dicentrics. 
By applying a correction to fraction f to compensate for the selective loss 
of irradiated cells due to interphase death and mitotic delay, the originally 
exposed fraction of cells (F) can be calculated using equation 6.4, and this 
original fraction can be taken to indicate the proportion of the body 
exposed in an in vivo irradiation (IAEA 1986). 
F= f Ip 
1- j+j/p 
(Equ 6.4) 
The surviving fraction ( p) for the selective loss of cells is assumed to follow 
the equation : 
p = exp ( - DI Do) (Equ 6.5) 
where D is the dose to the irradiated scored fraction (J) and Do the dose 
required to reduce the number of irradiated cells by a factor e due to 
interphase death. There is experimental evidence that the value of D0 lies 
between 3 and 8 Gy as determined for in vitro irradiated lymphocytes 
(Lloyd et al., 1991 ). It was decided to fix the value of 0 0 at 8 Gy for the 
purpose of the present analysis because it was suggested that in vivo the 
lymphocytes may suffer less radiation induced interphase death than in in 
vitro (Lloyd et al., 1991). 
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This technique applies very well to distributions of dicentrics (Lloyd et al., 
1991 ). However if the technique is applied to a distribution of MN two 
problems arise. Firstly the unirradiated fraction has a level of MN which 
typically may be 1 or 2 in 100. These may not be negligible whereas for 
dicentrics a typical background value is 1 in 1000 which can be ignored 
and a yield of zero assumed for the unirradiated fraction. Secondly 
because it is known that MN are overdispersed for whole-body exposure, 
as confirmed by the distributions at all the data points (except the zero 
dose value) shown in Table 4.3, (which may be considered equivalent to 
whole-body exposure) the assumption that the Poisson distribution applies 
to MN in cells which have been irradiated breaks down. 
The negative binomial method. According to Lloyd et al. (1991) the 
deficiencies of the contaminated Poisson method may be overcome by 
assuming that the MN in the irradiated fraction follow a negative binomial 
distribution. To describe the overdispersion by the negative binomial two 
parameters are required, namely Sand 8. 8 is a dispersion parameter. The 
parameter 1/8 is the ratio of variance to mean, so that 8 must lie between O 
and 1 and will typically lie between 0.7 and 0.9 for MN (Lloyd et al., 1991 ). 
The parameter S ought to be an integer but could be treated as a variable if 
the factorials are replaced by the appropriate r function. Lloyd and his co-
workers (1991) derived the following maximum likelihood equations 
whereby the parameters f, 8 and Scan be solved : 
0£09.L = 0 (Equ 6.6) 
of 
0£09.L = 0 (Equ 6.7) 
08 
0£09.£ 0 (Equ 6.8) 
as 
(Where£ is the likelihood of the observations no, n,, n2 etc). 
Th~se equations were solved numerically by minimising routines 
developed by Edwards and Murray (personal communication) whereby Log£ 
is minimised. The minimising routines, NAG routine E04JBF and the 
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Levenberg-Marquardt were used for this purpose (Press W., 1986; Murray 
et al., 1981 ). In an attempt to simplify the computation it was assumed that 
for the basic negative binomial the variance to mean ratio (1.25 in the 
present study) is fixed. When analysing the data, allowing all the 
parameters f, 8 and S to float, it was not always possible to obtain a 
sensible solution. It was decided to fix the parameter 8 at 0.8 for the 
purpose of the present analysis, the results of which are shown in Table 
6.4. Having obtained the values of the parameters f, 8 and S the mean 
yield of MN per cell could be calculated using equation 6.9 below (Lloyd et 
a/., 1991 ). 
y= S (1-8)/8 (Equ 6.9) 
By substituting y in the original, in vitro determined, dose-response curve, 
the dose D to the irradiated fraction, and the irradiated fraction F, was 
deduced. 
4. RESULTS 
4.1 Half-body irradiations 
The lymphocyte cultures prepared from all four blood samples obtained 
from the two donor patients who received half-body irradiation failed. It was 
not possible to score 100 BNC on any four slides originating from either 
pre- or post-exposed blood samples. 
4.2 Fractionated partial-body exposure 
The average yields of MN and their intracellular distribution in BNC from 
blood samples obtained from six donor patients before treatment, and after 
administering different tumour dose fractions at regular time intervals, are 
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Table 6. 1 Intracellular distribution of MN in CB lymphocytes of patients before 
and during radiotherapy. The dispersion index a2/y and standard unit normal 
deviate (µ) are also listed 
Equivalent Blood Number of MN per 500 
whole-body sampling MN distribution in BNC BNC BNC (± 1SE) a2(y 
dose (cGy) intervals observed 
(From table 5.1) 0 1 2 3 4 5 
Patient: a 
0 Pre-Irr 576 6 582 5.2(±2.1) 0.99 
4 24h 500 12 1 513 13.6 (± 3.6) 1.12 
18 1w 574 18 2 594 18.5 (± 3.9) 1.15 
37 2w 537 18 3 2 560 26.8 (± 4.9) 1.55 
55 3w 521 20 6 3 550 37.3 (± 5.8) 1.66 
74 4w 503 24 5 3 1 536 43.8 (± 6.4) 1.77 
Patient: b 
0 Pre-Irr 511 13 524 12.4 (± 3.4) 0.98 
18 24h 484 18 3 505 23.8 (± 4.9) 1.20 
89 1w 506 32 6 2 546 45.8 (± 6.5) 1.39 
179 2w 472 45 7 3 1 528 68.2 (± 8.0) 1.48 
268 3w 391 44 9 5 2 451 94.2 (± 10.2) 1.66 
358 4w 484 101 39 5 3 1 633 166.7(± 11 .5) 1.44 
Patient: c 
0 Pre-Irr 554 14 568 12.3 (± 3.3) 0.98 
16 24h 505 15 3 523 20.1 (± 4.4) 1.25 
93 1w 444 31 6 1 482 47.7 (± 7.0) 1.30 
153 2w 463 53 10 1 1 528 75.8 (± 8.5) 1.32 
223 3w 476 59 16 2 1 554 91.2 (± 9.1) 1.37 
306 4w 492 93 30 4 2 1 622 143 (± 10.7) 1.43 
Patient: d 
0 Pre-Irr 470 9 479 9.4(±3.1) 0.98 
16 24h 487 17 2 506 20.8 (± 4.5) 1.15 
97 1wq 638 42 6 2 688 43.6 (± 5.6) 1.31 
179 2w 535 50 10 3 598 66.1 (± 7.4) 1.35 
260 3w 547 64 19 3 633 87.7 (± 8.3) 1.33 
341 4w 529 79 33 11 3 655 145.0 (± 10.5) 1.59 
Patient: e 
0 Pre-Irr 489 9 498 9.0 (± 3.0) 0.98 
41 24h 652 12 5 2 671 20.9 (± 3.9) 1.75 
Patient: f 
0 Pre-Irr 424 8 432 9.3 (± 3.3) 0.98 































given in Table 6.1. In this table tumour doses are substituted by the 
derived equivalent whole-body doses given in Table 5.1 . To compare the 
distribution of MN among BNC to a Poisson distribution, [using Papworth's 
U test (Papworth, 1970)], the dispersion index (cr2/y) and the standard unit 
normal deviate of this ratio, i.e. the µ-parameter in Table 6.1, were 
calculated as shown in Chapter IV, section 5. As shown by others (Prosser 
et al., 1988; Balasem et al., 1993) and the in vitro results of this study 
(Table 4.3) MN were distributed in a non-Poisson manner. They were 
significantly overdispersed in all the data points with th~ exception of the 
zero-dose values. There was some indication of a dose dependence of 
overdispersion, however, this was not a consistent phenomenon throughout 
all the data, and appeared patient dependent. 
4.2.1 Dose-response relationship of micronuclei in CB lymphocytes 
from patients receiving fractionated radiotherapy 
To investigate whether the dose-response data of individual patients, given 
in Table 6.1 could be pooled, a linear regression model was fitted on the 
induced MN yield of patients a,b,c and d. Subsequently, by means of an 
analysis of covariance, it was tested whether the four regression 
coefficients and y- intercepts, (given in Table 6.2) significantly differ from 
each other. 
Table 6.2 Regression coefficients and y- intercepts for induced MN 
yields in lymphocytes of patients receiving fractionated radiotherapy 
Patient Regression coefficient y-intercepts 
a 0,1058 (± 0,0126} 0,0148 (± 0,0031} 
b 0,0743 (± 0,0071) 0,0261 (± 0,0073) 
C 0,0800 (± 0,0037) 0,0250 (± 0,0033) 
d 0,0690 (± 0,0057} 0,0214 (± 0,0060} 
Standard errors are given in brackets 
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The null-hypothesis of equal regression coefficients and equal y- intercepts 
could not be discarded (p > 0.05). Consequently it was decided to pool the 
individual data sets in Table 6.1. 
The overdispersion of the MN frequency distributions was taken account of 
as described in Chapter IV when the data were curve fitted by iteratively 
reweighted least squares (Papworth, 1975). A fit of the dose-response 
data to the equation y = aD + c obtained by reweighted analysis (using the 
SAS/ST AT computer software package) yielded the following dose-
response function : 
y = 7.575 E-2 (± 2.963 E-3) 0 + 2.126 E-2 (± 2.085 E-3) 
(Standard errors are given in parenthesis) 
(Equ 6.10) 
The chi-squared value of 19.165, is approximately the same as the 
number of degrees of freedom 18, which points to an excellent fit. 
4.2.2 Biological dose estimates 
The relationship between measured doses of external radiation and the 
frequency of in vivo induced MN has been investigated (Fenech et al., 
1990; Gantenberg et al., 1991 ). However, no study has been reported to 
date in which dose estimates were obtained by relating in vivo induced MN 
frequency to a previously in vitro determined calibration curve, with the 
objective of comparing the physically calculated, equivalent whole-body 
doses with corresponding biological estimates. 
In the present study the biological estimates were calculated by 
substituting the in vivo data (MN frequencies) of Table 6.1 in the in vitro 
determined dose-response equation of Chapter IV, i.e. 
y = 0.0872 (± 0.0027) D + 0.0116 (± 0.0024) (Equ 4.5) 
The results are detailed in Table 6.3. 
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Table 6.3 Comparison of the physically determined equivalent whole-body 
doses with the biological dose estimates in patients undergoing radiotherapy 
MN/BNC Physical Biological MN/BNC Physical dose Biological 
(E-2) dose (cGy) dose (E-2) (cGy) dose 
estimates estimates 
(cGy) (cGy) 
Patient: a Patient: c 
1.04 0 2.46 0 15 (± 3) 
2.72 4 18 (± 3) 4.02 16 32 (± 3) 
3.70 18 29 (± 3) 9.54 93 96 (± 5) 
5.36 37 48 (± 4) 15.16 153 160 (± 7) 
7.46 55 72 (± 5) 18.24 223 196 (± 9) 
8.76 . 74 87 (± 5) 28.62 306 315 (± 12) 
Patient: b Patient: d 
2.48 0 15 (+ 3) 1.88 0 8 (± 3) 
4.76 18 41 (± 4) 4.16 16 34 (± 3) 
9.16 89 92 (± 6) 8.72 97 87 ( ± 6) 
13.64 179 143 (± 7) 13.22 179 138 (± 7) 
18.84 268 203 (± 9) 17.54 260 188 (± 8) 
33.34 358 369 (± 14) 29.00 341 319 (± 12) 
Patient: e Patient: f 
1.80 0 7 (± 3) 1.86 0 8 (± 3) 
4.18 41 35 (± 4) 5.26 44 47 (± 4) 
(Standard errors of biological estimates are given in brackets; physical doses 
are from Table 5. 1) 
4.2.3 Calculations of localized dose and irradiated body fraction 
Contaminated Poisson method : Despite the discrepancies regarding the 
use of the contaminated Poisson method for calculating the irradiated body 
fraction, F and the localized dose, D to this fraction from MN data (see 3.2) 
as an exercise this method has been applied to the single exposure data 
points of patients e and f, as given in Table 6.4. 
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Negative binomial method : Applying the negative binomial method to the 
MN data obtained 24 h after the first exposures of patients a,b,c and d no 
solutions of the relevant equations were possible. Patients e and f 
received much larger single exposures and estimates of the localized dose, 
D and the irradiated body fraction, F were obtained (given in Table 6.4). 
This method was also applied to two sets of data points obtained after 4 
weeks of fractionated exposure of patients b and c respectively. 
Table 6.4 Estimates of localized dose D, irradiated fraction F, and 
integral dose ID, in patients having received radiotherapy 
Physical parameters 
Patient Weight (kg) Vol. Irr (cc) 
e 76.4 4707 
f 81.8 5221 
b 46.0 7389 
C 55.4 7602 
Biological estimates : Contaminated Poisson method 
Patient D (Gy) (±1SE) F (± 1SE) 
e 9.31 (2.95) 0.15 (0.05) 
f 6.01 (2.62) 0.26 (0.08) 
Biological estimates: Negative binomial method 







12.10 (5.41) 0.13 (0.06) 
5.91 (4.31) 0.16 (0.09) 
17.49 0.88 
15.92 0.85 
f = fraction of scored cells exposed 
s = binomial parameter 
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F D (Gv) ID(koGy) 
0.06 10 31.70 
0.06 10 35.62 
0.16 40 164.24 
0.14 39.6 169.73 
*f(±1SE) ID (kaGv) 
0.05 (0.02) 35.57 
0.10 (0.03) 47.70 
*f{±1SE) ID {kgGy) *s 
0.03 (0.02) 28.66 4.25 
0.08 (0.06) 39.64 2.10 
0.46 370.30 6.15 
0.44 387.50 5.60 
5. Discussion 
5.1 Factors responsible for modification of the experimental protocol 
Originally it was intended to perform the MN assay on approximately 15 
patients who received single doses of half-body irradiation. However, 
after performing the MN assay in 2 patients who had received half-body 
radiation , it was noted that the number of micronuclei was too small to 
yield reliable results (Section 4.1 ). This may be caused by previous 
chemotherapy and post irradiation antiemetic therapy of the patients. 
This therapy included the administration of high doses of dexamethasone, 
a corticoid with a well-known anti-proliferative action. 
As a second approach it was decided to select approximately 10 patients 
representing a range of relatively large irradiated volumes distributed 
throughout the body. Amongst these were 4 patients treated for 
advanced carcinoma of the breast. These were subjected to multi-planar 
treatment plans for which the required dose-volume histograms could not 
be calculated with the existing computational facilities. Consequently the 
breast patients had to be rejected. 
Finally only the data obtained from 6 patients, selected according to the 
criteria given in Chapter V, Section 3, were used for MN analysis. 
Obtaining the data was a time consuming process which extended over 
more than two years and consequently precluded the inclusion of more 
patients in the study. 
5.2 MN in unexposed human lymphocytes 
The MN frequency in lymphocytes of patients, not exposed to irradiation 
given in Table 6.1, falls within the normal range described in previous 
studies (Fenech and Morley, 1986). However, the pretreatment baseline 
frequencies of the patients are not only higher than that of the healthy 
donors but there is also a much greater interindividual variability. When 
the average age of the patients tested in this study (70 years, ranging 
from 54 to 86 years) is compared with the average age of healthy donors 
(38 years ranging from 28 to 57 years) the difference in baseline MN 
frequency can most likely be attributed to age dependence (Norman et al., 
1985; Fenech and Morley, 1986 and Thierens et al., 1991 ). 
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Other factors may also play a role in MN frequency. The results of Xue et 
al. (1992) show that smoking significantly increases MN frequency in 
lymphocytes as compared with healthy non-smokers. Furthermore alcohol 
significantly increases and tea decreases the MN frequency induced by 
smoking. It was also suggested (Gantenberg et al., 1991) that the cancer 
itself could be responsible for a higher MN baseline frequency. It is 
important to note that Fenech et al. (1985) could find no evidence that the 
Cyt- B method in itself caused any increase in micronuclei. 
It was shown by Thierens et al. (1991) that for in vitro irradiation of whole 
blood, doses lower than 0.3 Gy could not be unequivocally detected with 
the MN assay due to the variability of the baseline MN frequency within the 
donor population. The latter as well as the interindividual variability 
reduces the low-dose sensitivity of the test when, as usually will be the 
case, a population control value rather than an individual pre-irradiation 
frequency must be used. However with regard to accidental exposure 
where there is a large number of potentially exposed people, the initial 
requirement is to identify those who have received a large, possibly life 
threatening dose, so that treatment can be concentrated where it is most 
needed. In this case these inaccuracies of the -MN test for detecting low 
doses are not important and are outweighed by the potential for rapid 
analysis afforded by the assay. Indeed, Thierens et al. (1991) have shown 
that the uncertainty of the dose is not seriously reduced at higher dose 
levels. On the other hand if the individual pre-irradiation baseline value is 
known, the absorbed dose could be deduced from the number of radiation 
induced MN instead of the total number of MN, thereby eliminating the 
variation in the baseline frequency within a normal population. 
5.3 MN yield as qualitative biomarker of radiation exposure 
The observed MN yield per 500 binucleated cells for measurements 
performed at different tumour doses are illustrated in Fig 6.1 . For each of 
the four patients a pronounced dose-dependent increase in MN yield was 
observed. Consequently these findings indicate that MN evaluations in 
persons who receive fractionated high-dose, localized exposures can serve 
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Fig 6. 1 Dose-response relationship of MN in binucleated 
lymphocytes (BNC) exposed in vivo in patients receiving 
fractionated radiotherapy. 
In principle the extent of MN induction should be similar in patients 
irradiated at the same site with similar integral doses. This was found to be 
the case with patients c and d of whom the integral doses were 
approximately the same. 
5.4 MN in human lymphocytes irradiated in vitro and in vivo 
Another requirement which the MN assay has to meet to be useful as 
biological dosimeter lies in the answer to the question as to whether there 
are differences in the dose-response relationship following in vitro and in 
vivo exposures. 
Since there is no significant difference between the in vitro and in vivo 
radiosensitivity of human lymphocytes when chromosomal aberrations are 
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used as a measure of sensitivity (Buckton et al., 1971; Clemenger and 
Scott, 1971) it is reasonable to expect the same for micronuclei , which are 
derived from chromosomal aberrations. Gantenberg et al. (1991) found 
that comparison of in vitro and in vivo results points to a slightly smaller 
increase in micronuclei after in vivo exposure, however there was no 
statistically significant difference. 
A dose-response relationship was estimated from the pooled data of all the 
patients given in Table 6.1. It was assumed that: 
(a) fractionation of radiotherapy resulted in a 
significant dispersal of the total dose over the 
lymphocyte pool and, 
(b) the variation in concentration of lymphocytes 
within the different irradiated sites of the patients 
was not significant. 
The data were fitted by the iteratively reweighted least squares method to 
derive maximum likelihood estimates of the parameters a. and c in the 
equation y = a.D + c. These parameters as well as those previously 
obtained from in vitro exposure of donor blood samples are given in Table 
6.5. 
Table 6.5 Dose coefficients and y- intercepts obtained with in vitro 
and in vivo exposure, with standard errors in brackets. 
Exposure Coefficient (a.) y-intercept (c) 
In vitro 
0.0872 (± 0.0027) 
0.0116 (±0.0024) 
In vivo 0.0757 (± 0.0030) 0.0213 (±0.0021) 
It was found that there was no statistical reason to discard the null-
hypothesis of equal regression coefficients. However the hypothesis that 
the y- intercepts are the same should be discarded at the 5% confidence 
level. This difference might be expected, as the pre-treatment baseline 
micronucleus frequencies of the patients were higher than that of the 
healthy donors. 
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As reported by Gantenberg et al. (1991 ), the dose coefficient obtained with 
in vivo exposure was slightly lower than that from in vitro exposure, but the 
difference was not statistically significant. Gantenberg and his co-workers 
present as explanation for this difference the disparity in the dose rates of 
their in vitro (1 Gy min·1 ) and in vivo (0.033 Gy min·1 ) exposures. The dose 
rates used in the present study were low for in vitro exposures (0.88 Gy 
min·1 ) and high for in vivo exposures (2.5 Gy min·1 ). It is suggested that 
two other explanations exist for the gradient of the dose-response curve 
obtained from in vivo exposures being lower than that obtained from in vitro 
exposures. 
Firstly, the in vitro exposures were administered in a single exposure, 
compared to the conventional radiotherapy protocol of fractionated 
exposure. Radiation induced MN are mainly acentric chromosomal 
fragments from the cell nucleus, which are observed in the cytoplasm 
(Streffer, 1993). In several studies (ICRP, 1990) it was shown that the 
probability for chromosomal repair, particularly at higher doses when a 
damaged cell may be expected to contain two or more acentric fragments, 
was much higher with dose fractionation than with single exposures. This 
will have the effect of depressing the observable MN yield, resulting in a 
lower gradient of the dose-response curve with in vivo exposures. 
Secondly, in the case of in vivo exposure, evaluation was difficult, because 
fewer binucleated cells were obtained, and the quality of the cells was 
inferior to that of cells from the in vitro exposures. This was probably due 
to medication that accompanied the radiation treatment of patients and 
possibly the disease itself. This phenomenon was also perceived by 
Gantenburg et al. (1991 ). Consequently the dose-response relationship 
obtain from the patient data, compared to that obtained from healthy donor 
data, may then be considered less reliable for dosimetry purposes. 
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5.5 Application of the in vitro results for in vivo dosimetry 
The major objective of this study was to evaluate the usefulness of the MN 
assay as an in vivo dosimetry system for fractionated partial-body 
exposure. The equivalent whole-body dose estimates and the 
corresponding doses obtain from physical measurement and calculation 
are given in Table 6.3. To compare the two sets of data, whole-body dose 
estimates below approximately 40 cGy were discarded because: 
(a) the relatively high pre-treatment baseline, and 
interindividual variability of the MN frequency, renders 
the low dose estimates unreliable and, 
(b) at the 95% confidence level, doses lower than 30 cGy 
can not be unequivocally detected with the CB 
micronucleus assay due to the poor statistical accuracy 
when scoring approximately 500 cells (Thierens et al., 
1991 ). 
In order to compare the two sets of doses (biological [BD] and physical 
[PD]) the conventional linear model was fitted to the data of individual 
patients. This was followed by a covariance analysis to determine if data of 
individual patients could reasonably be pooled to provide a single model 
from physical measurements to biological measurements. 
They- intercepts (f3), and gradients (a), obtained from the linear regression 
model, BD = f3 + a (PD) are given in Table 6.6. 
Table 6. 6 y-intercepts and regression coefficients, with standard 
errors, for individual patients 
Patient Coefficient (a) y-intercept (~) 
a 1.06 (± 0.07) 10.1 (± 3.5) 
b 0.99 (± 0.22) -20.6 (± 52.9) 
C 1.03(±0.15) -5.3 (± 31.2) 
d 0.92 (± 0.17) -18.1 (±40.9) 
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Data given in Table 6.6 indicated that the null-hypothesis of equal y-
intercepts and equal regression coefficients could not be discarded. 
A linear regression analysis of the pooled data of all the patients ( excluding 
the very low dose data points) indicated that the relationship between the 
two sets of doses could be described by 
BD = 0.896 PD + 6.258 (Equ 6.11) 
The linear regression fit representing this expression is given by the solid 
line in Fig. 6.2. None of the points deviate appreciably from the regression 
line. Only one point (the second last point of patient d) deviated with 
approximately two standard deviations from the line. This was insufficient 
to discard this point. 
Subsequently it was investigated if the intercept could be zero. It was 
found that such a hypothesis could not be discarded. When it was 
assumed that the line must go through the origin, the following expression 
was obtained : 
BD = 0.936 PD (Equ 6.12) 
The main reason for this comparison was to determine if the biological 
estimates fell within the statistical variation of the physical measurements. 
The results of the study suggested that the biological estimates were 
slightly low. There is, however, inadequate statistical evidence to discard 
the null-hypothesis that the gradient of Equ. 6.12 is equal to one. (The 
Bland and Altman statistical procedure yielded p=0.1177, and the 95% 
confidence limits for the mean difference between the two measurements 
ranged from -24.20 to 2.97. This interval includes the O value and this 
confirms the hypothesis). 
There are no precise criteria for deciding on the accuracy that a biological 
estimate of dose needs to achieve. Generally, biological data carry more 
uncertainty than physical measurements because of factors such as 
individual variability and sampling statistics. When considering the needs 
of radiological protection, particularly at high doses, precision is not too 
important, as medical intervention tends to follow the appearance of 
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deterministic symptoms rather than anticipating them due to forewarnings 
from dosimetry. 
Lloyd et al. (1987) suggested that a dose estimate within 30% of the 
estimated physical dose ("true" dose) is a good accuracy to attain. The 
limits of the interval presenting 30% of the "true" dose, are indicated by the 
broken lines in Fig. 6.2. Taking a generalised criterion that a dose estimate 
within 30% of the "true" dose is sufficiently accurate for radiological 
protection purposes then all the equivalent whole-body dose estimates 
obtained with fractionated partial-body exposure are acceptably close to 
the "true" dose values. 
After a major radiation incident segregation of casualties into the three 
categories, namely below 1.5 Gy, between 1.5 and 5 Gy and above 5 Gy is 
a reasonable initial objective (Prosser et al., 1989). From the results 
presented in this thesis it can be stated that MN data can provide dose 
estimates accurate enough to confirm the triage category into which the 
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Fig 6.2 Correlation between estimated physical dose and biological 
dose in patients undergoiging fractionated radiotherapy, 
with 30% tolerance lines. 
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5.6 Estimates reflecting non-uniformity of exposure 
In Table 6.4 the dose to the irradiated body fraction and the size of this 
fraction, estimated according to the contaminated Poisson and negative 
binomial methods respectively, are compared with the corresponding doses 
obtained from physical measurement and calculation. In applying either of 
these methods there is the basic underlying assumption that there are only 
two types of cells i.e. a simple uniformly irradiated fraction and an 
unirradiated fraction. 
During a localized single treatment only a fraction of the lymphocytes will 
lie within the radiation field. Lymphocytes are distributed throughout the 
body, principally in the lymph nodes, spleen, bone marrow, thymus, and the 
lymphoid tissue of the gut. Trepel ( 197 4) has estimated the distribution of 
lymphocytes within these compartments and other tissue in the normal 
adult human. Changes in the physiological state of an individual can alter 
this distribution, but at present these alterations are known only 
qualitatively. 
Aside from those that are circulating in the blood, the lymphocytes 
essentially remain fixed during a single radiation treatment and therefore, if 
the distribution of dose throughout the treatment volume is uniform, all the 
lymphocytes which are exposed will receive the same dose. Lymphocytes 
within the blood do not receive a uniform dose during a treatment since 
they move in and out of the field. Few lymphocytes are in the blood at any 
one time (2.2% of the total number, [Ekstrand and Dixon, 1982]) so that, 
because these cells receive only a small portion of the dose, these cells 
can be considered to be outside the radiation field. 
The contaminated Poisson and negative binomial methods were applied to 
the data of patients e and f who each received a single localized exposure 
of 1 OGy. Theoretically, the contaminated Poisson method is not applicable 
to this data, because the assumption that the Poisson distribution applies 
to MN in cells which have been irradiated, is not valid. It is known that MN 
are overdispersed compared with a Poisson distribution (Prosser et al., 
1988; Lloyd et al., 1991 and the distributions given in Tables 4.1 and 6.1 
respectively). 
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Notwithstanding this argument there is very little difference between the 
corresponding estimates of local dose and irradiated body fraction (Table 
6.4) from the two methods. The reason for the unexpected suitability of the 
contaminated Poisson method for this analysis probably lies in the 
overdispersion-dose relationship. A quantitative estimate of how 
overdispersion varies with dose is not available. Some information on this 
is given by Prosser et al. (1988) and Littlefield et al. (1989) but the results 
were variable. Clearly further work is required to clarify this point. 
Micronuclei data obtained from lymphocytes exposed in vivo to ionising 
radiation has to date not been analysed using the negative binomial 
method. In the analysis presented here it was necessary to find 
parameters of the contaminated negative binomial distribution and to 
compare these with the corresponding values obtain from in vitro results. 
The background yield of micronuclei was assumed to be 0.0116, which was 
the fitted control level for the in vitro observations. For 8 a value of 0.8 was 
assumed, because 118 (the ratio of variance to mean) according to the in 
vitro data points was 1.25. These values are similar to the corresponding 
background yield (0.012) and 8 value (0.8) used by Lloyd and his co-
workers (1991) in the analysis of their in vitro MN data. 
Bearing in mind all the uncertainties, the doses to the irradiated volume are 
reasonable, taking a generalised criterion that a dose estimate within 30% 
of the "true" localized dose is sufficiently accurate for radiological 
protection purposes. It should be noted that even in the patients receiving 
a single exposure of 10 Gy there were between 97 and 98% of cells seen 
that did not contain any aberrations. This information in itself is of 
immediate qualitative value as an indication that the greater proportion of 
the cells has been spared. The implication from this is that there is likely to 
be natural recovery of bone marrow. In a highly irradiated subject whose 
lymphocytes are analysed by the micronucleus assay, this would be 
apparent after relatively few cells had been scored. The clinician could 
then be informed early on with the expectation that when a larger sample 
has been analysed a more quantitative estimate of inhomogeneous 
irradiation would be available using the methods described in this Chapter. 
Data in Table 6.4 suggests a discrepancy with regard to the irradiated 
volume. For the latter the biological estimates seems to be consistently 
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higher than the physically estimated volumes. However using the negative 
binomial method the deviation from the physically estimated volumes is 
only approximately one standard error and with the contaminated Poisson 
method two standard errors. 
There are three possible explanations for this discrepancy. The first is that 
the fraction of irradiated lymphocytes is greater than that estimated using 
Matsubara and co-workers' ( 197 4) report as a basis. These workers 
suggested that the fraction of irradiated lymphocytes could be 
approximated by the volume of the irradiated site relative to body weight, 
i.e. an even distribution of lymphocytes throughout the body. From the 
data of Trepel (1974) on the distribution of lymphocytes this approximation 
does not apply in the strict sense to single partial-body exposure. In fact it 
may well be that the amount of lymphocyte-bearing tissues within the 
irradiated fraction is significantly greater than the approximated 6% (see 
Table 6.4) of the total. Furthermore the nature of the disease is such that 
the treated area may be infiltrated with lymphocytes. Thus the fraction of 
lymphocytes which were exposed in the treatments is possibly greater than 
that applicable to normal individuals. 
The second explanation is that the value of Do may be incorrect The 
survival curve for lymphocytes may be represented by a simple 
exponentially decreasing function (Equ 6.5) as described by Lloyd et al. 
(1973). In this equation D0 is the dose for which the surviving fraction p, is 
1/e. Estimated values for D0 are determined for in vitro irradiation of 
lymphocytes and vary considerably. The maximum of these values, i.e. 
8 Gy, was applied in calculating the irradiated fraction, F. Nevertheless, 
considering these fractions given in Table 6.4, there is a tendency for the 
biological estimates to be somewhat high. This leads to the possibility that 
the assumed value for D0 is too low. It is possible that in in vivo the 
lymphocytes may suffer less radiation induced interphase death than in in 
vitro. Sasaki (1978) has indicated that chromosome repair does not take 
place except in the case of activated lymphocytes or lymphocytes exposed 
in an artificial medium. Other researchers have disputed this (Virsik and 
Harder, 1980). They found that repair does occur and it is virtually 
complete within two hours of the irradiation. It was suggested by Lloyd et 
al. (1992) that in vivo some stem cells could multiply and in this way cause 
an apparent radioresistance of lymphocytes in vivo. Consequently a good 
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case can be made for more research to extend the experimental basis for 
Do values. 
A third explanation for the discrepancy regarding the irradiated fraction (F) 
may lie in the basic assumption that when these methods for calculating F 
are applied to observations in patients the dose should be uniform 
throughout the irradiated volume. In general the dose-volume histograms 
(Chapter V) indicate that the treatment plans of the patients indicate 
reasonable dose uniformity. However, only about 20% of the irradiated 
volume received 100% of the tumour dose, i.e. 10 Gy. Consequently the 
average dose over the total irradiated area will be less than 1 O Gy, but the 
product of the average dose and the irradiated volume (mass) i.e. the 
integral dose as calculated using the contaminated Poisson and negative 
binomial methods must still correspond with the physically determined 
integral dose. 
In view of the uncertainty in quantifying D0 for lymphocytes irradiated in 
vivo, it was decided to ignore the correction for the selective loss of cells 
due to interphase death and mitotic delay in calculating the integral dose. 
Consequently the fraction of cells irradiated and seen (J) was taken to be 
the originally exposed fraction of cells (F). This fraction (J) is therefore 
assumed to represent the proportion of the body exposed during in vivo 
irradiation. 
There is a good agreement between the physically determined integral 
doses and the integral doses derived from the dose values obtained by 
means of the negative binomial method (Table 6.4). It is however, not 
recommended that the assumption (F = f) should be accepted without 
reservation for in vivo exposure of lymphocytes, because interphase death, 
although probably less than for in vitro exposure, must also occur with in 
vivo exposure of lymphocytes. 
5.7 Applying the negative binomial method to MN data obtained from 
fractionated partial-body exposure 
A basic requirement in the negative binomial method is that the irradiated 
volume (and therefore the fraction of lymphocytes within the irradiated field) 
is constant during treatment. During any single treatment, which usually is 
completed within about 3 - 5 minutes, the fraction of lymphocytes within the 
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irradiated volume will comply with this requirement. Typically the time 
between treatment fractions is at least 24 hours. This is sufficient for the 
lymphocytes to redistribute themselves, either within or outside the 
radiation field. Consequently estimates reflecting the non-uniformity of 
exposure, i.e. the localized dose and irradiated fraction, by means of the 
negative binomial method was not possible from data obtained with 
fractionated partial body exposure. To demonstrate this the MN data points 
of patients a and b obtained after 20 daily fractions of exposure were 
selected for analysis. As indicated in Table 6.4 this analysis provided 
estimates of localized dose and irradiated fraction which do not agree with 
the corresponding physically measured values. 
6. Conclusions with regard to future studies 
Although the procedures used in the present study have been available for 
several years, it is applied here for the first time to MN data obtained from 
lymphocytes exposed in vivo. This study has revealed two related problem 
areas for both of which a good case can be made for more research to 
extend the applicability of the relevant experimental methods and analysis 
used in this study, as discussed below. 
6.1 Overall reliability of the equivalent whole-body dose concept 
The fundamental objective of this study was to show that an equivalent 
whole-body dose estimate, obtained from relating an in vivo induced MN 
yield to an in vitro dose-response calibration curve, is sufficiently accurate 
for clinical management of accidental partial-body irradiation. 
In estimating the equivalent whole-body dose values given in Fig 6.2 the 
fraction of irradiated lymphocytes is approximated by the volume of the 
irradiated site relative to the body weight. This approximation, however, 
has to take into account some important variables. For example, lung 
tissue is of a lower density than other tissues, so that the irradiated volume 
represents a relatively lower tissue mass. Another important factor is the 
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variability in the proportion of lymphoid tissue and bone marrow in the 
exposed site, so that the consequences of partial-body irradiation may be 
very dependent on the irradiation site (Liniecki et al., 1983; Savage and 
Breckon, 1985). 
The patients used in this study did have a variety of tumours (as regards 
pathology and volume) and integral doses, but they were all located in the 
pelvic area. Consequently it is necessary to confirm the repeatability of the 
graph shown in Fig. 6.2 for other tumour sites, before it can be accepted 
with confidence. Research in this regard may involve three-dimensional 
dose calculations from more complicated multi-planar treatment plans. 
Applying the same techniques to obtain estimates of the equivalent whole-
body dose from the MN frequency ratio following fractionated radiation 
therapy of body sections other than the pelvic area, may show the 
assumption of lymphocytes being evenly distributed throughout the body to 
be incorrect. An alternative approach may then be to develop a model 
whereby the amount of lymphocyte-bearing tissue within the irradiated 
volume can be estimated. The data of Trepel, (1974) on the distribution of 
lymphocytes within each lymphoid compartment could be used as a starting 
point to calculate the fraction of lymphocytes in the irradiated volume. 
6.2 Extending localized dose estimates to fractionated partial-body 
exposure 
Further research in this field should be directed at development of methods 
for analysis of MN data from persons having received fractionated 
inhomogenous exposure, with the aim of estimating the localized dose 
reflecting the non-uniformity. A possible means to describe data obtained 
after several fractions of exposure is to model the MN distribution after 
each fraction separately, assuming thorough mixing of lymphocytes. 
This and other considerations, such as interphase cell death, have been 
taken into account by Ekstrand and Dixon (1982) when developing a 
mathematical equation describing the dose-response relationship for 
lymphocyte chromosome aberration yields occurring following fractionated 
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partial-body irradiation. The same technique could possibly be used to 
make an estimate of the localized dose from the MN frequency ratio, 
following fractionated partial-body radiation therapy. Results in this regard 
may prove useful in the interpretation of MN yields as a sophisticated form 
of in vivo dosimetry. 
6.3 Future prospects of the MN assay 
A number of biochemical and cytological assays have been proposed as 
biological indicators of exposure (see Chapter Ill). They suffer from 
drawbacks concerning factors such as poor sensitivity, particularly to doses 
below 1 Gy, and fluctuating inter- or intra-donor variability in response. In 
some instances the response to irradiation is too transient for practical 
application. Cytogenic dosimetry however stands out as being the most 
sensitive and widely used of the possible biological dosimeters. 
However in this regard much work remains to be done on the yield of MN 
as a function of the distribution of dose in space and time and of the quality 
of radiation. Nevertheless, the comparison of biologically and physically 
recorded whole-body doses illustrates that useful estimates can already be 
made of the dose absorbed by the circulating lymphocytes in people 
accidentally exposed to acute doses of radiation. The relationship of MN 
frequency and medical risk for leukemia and other late effects of radiation 
remains a study for the future. A major drawback on progress in this area 
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